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Resumo 
 
A aquacultura é um dos setores da área alimentar que mais tem crescido nos 
últimos anos. No entanto, o aparecimento de microrganismos patogénicos, 
incluindo bactérias multirresistentes, e a sua disseminação no meio ambiente 
tornou-se um problema para a indústria de aquacultura. Este facto leva a que 
seja necessário o desenvolvimento de estratégias menos lesivas para o 
ambiente de forma a permitir o crescimento sustentável da aquacultura. A 
terapia fágica surge como uma alternativa potencialmente viável e eficaz para 
inativar bactérias patogénicas em aquacultura. O principal objetivo deste 
trabalho consistiu na avaliação da eficácia da terapia fágica para inativar 
bactérias patogénicas de peixes. Foi avaliado o efeito do uso de cocktails de 
fagos e de lisozima na eficiência da terapia fágica. Os ensaios de terapia 
fágica foram realizados com a bactéria Vibrio parahaemolyticus e com três 
fagos produzidos sobre esta bactéria (VP-1, VP-2 e VP-3). A dinâmica de 
interação fago-bactéria foi caracterizada em meio de cultura Tryptic Soy Broth 
através da quantificação do hospedeiro por incorporação e da quantificação 
dos fagos pela técnica da dupla camada de agar. Os três fagos foram 
testados isoladamente e em cocktails de dois ou três fagos. A eficiência de 
inactivação bacteriana pelos três fagos foi testada com diferentes 
concentrações de lisozima (gama 0,8 µg mL-1 a 20 mg mL-1). Como, para 
aplicar com sucesso a terapia fágica, é importante ter informação sobre as 
características dos fagos, a gama de hospedeiros, a sua sobrevivência na 
água da aquacultura, bem como o seu número e tempo de explosão, foram 
determinados. Para o estudo da gama de hospedeiros de bacteriófagos usou-
se a infeção cruzada. Para determinar a sobrevivência dos fagos na água 
marinha foi usada a técnica da dupla camada de agar. O número e o tempo 
de explosão foram determinados através da determinação das curvas de 
crescimento síncrono. O uso de cocktails de dois e três fagos foi 
significativamente mais eficaz (redução de 4 log após 2 h de tratamento) do 
que o uso dos fagos VP-1, VP-2 e VP-3 sozinhos (redução 0,6, 0,8, e 2,6 log 
para os fagos VP-1, VP-2 e VP-3, respectivamente, após 2 h de tratamento). 
A combinação de lisozima e fago apresentou melhor atividade inibidora em 
comparação com a atividade do fago sozinho. Os fagos VP-1 e VP-2 foram 
mais eficazes na inativação bacteriana (redução de cerca 4 log após 6 - 8 h 
de tratamento) na presença de altas concentrações de lisozima do que o fago 
VP-3. No entanto, o fago VP-3 foi mais eficaz na presença de baixas 
concentrações de lisozima (redução de 3,2 log, depois de 2 h de tratamento). 
Os resultados da infeção cruzada mostraram que os fagos de Vibrio 
parahaemolyticus inoculados noutras bactérias infetaram também Vibrio 
anguillarum e Aeromonas salmonicida, apresentando uma eficiência de 
infeção elevada. Os ensaios de sobrevivência dos fagos na água de 
aquacultura mostraram que estes permanecem viáveis por longos períodos 
de tempo (mais de 5 - 7 meses). O fago VP-3 apresentou um número de 
explosão maior e um período latente menor (42 e 40 min, respetivamente), do 
que os outros dois fagos (9 e 120 min e 15 e 90 min, respetivamente, para o 
fago VP-1 e VP-2). Em conclusão, a utilização de cocktails de fagos parece 
ser uma abordagem eficaz para o tratamento de vibrioses. A inativação 
bacteriana é mais eficiente e ocorre mais cedo quando são usados os 
cocktails de fagos, mas a sua utilização in vitro não impede o recrescimento 
bacteriano após o tratamento, retardando, no entanto, o recrescimento da 
bactéria. A aplicação de fagos com lisozima, para eliminar ou reduzir 
bactérias patogénicas de peixes em aquacultura, pode ser uma estratégia 
promissora, nomeadamente quando os fagos disponíveis são menos 
eficientes. A utilização de fagos com um alto número de explosão e um 
período latente curto aumenta claramente a eficiência da terapia fágica. 
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Abstract 
 
Aquaculture is one of the fastest growing food industry sectors in the world in 
recent years. However, the appearance of pathogenic microorganisms, 
including multirresistant bacteria, and their dissemination in the environment 
has become a problem for the aquaculture industry. This means that it is 
necessary to develop less harmful strategies to the environment to allow a 
sustainable growth of the aquaculture systems. Phage therapy emerges as a 
potential alternative to inactivate pathogenic bacteria in aquaculture. The main 
objective of this study was to assess the efficacy of phage therapy to 
inactivate fish pathogenic bacteria. The use of phage cocktails and lysozyme 
was also evaluated on the efficiency of phage therapy. The phage therapy 
assays were performed with the bacterium Vibrio parahaemolyticus and with 
three phages produced on this bacterium (VP-1, VP-2 and VP-3). The 
dynamics of phage-bacteria interaction was characterized in Tryptic Soy Broth 
through host and phage quantification, respectively by pour plate and by the 
double-layer agar technique. The three phages were tested alone and in 
cocktails of two or three phages. The efficiency of the bacterial inactivation by 
the phages was tested at different lysozyme concentrations (range 0.8 µg mL-
1 to 20 mg mL-1). As the selection of bacteriophages is a key factor for the 
success of phage therapy, the host range, their survival in aquaculture water, 
as well as the burst size and the explosion time, were determined. The cross-
infection was used to determine the phage host range. To determine the 
survival of the phages in marine water, the double-layer agar technique was 
used. The burst size and the explosion time were calculated by the one-step 
growth curve analysis. The use of cocktails of two and three phages was 
significantly more effective (reduction of 4 log at 2 h of treatment) than the use 
of the VP-1, VP-2 and VP-3 phages alone (reductions of about 0.6, 0.8 and 
2.6 log, at 2 h of treatment respectively for the VP-1, VP-2, and VP-3 phages). 
The combination of phage plus lysozyme showed a better inhibitory activity 
when compared with the activity of the phage alone. The VP-1 and VP-2 
phages were more efficient to inactivate the Vibrio (reduction of about 4 log 
after 6 - 8 h treatment), in the presence of high concentrations of lysozyme, 
than the VP-3 phage. However, the VP-3 phage was more efficient in the 
presence of low concentrations of lysozyme (reduction of 3.2 log after 2 h of 
incubation). The results of the cross-infection showed that the phages of 
Vibrio parahaemolyticus also infect Vibrio anguillarum and Aeromonas 
salmonicida with high efficiency. The assays of phage survival in aquaculture 
water showed that the phages remain viable for long time periods (more than 
5 - 7 months). The VP-3 phage presented a higher burst size and a shorter 
latent period (42 and 40 min, respectively) than the other two phages (9 and 
15 and 120 min and 90 min, respectively, for the VP-1 and VP-2 phages). In 
conclusion, the use of phage cocktails appears to be an effective approach to 
treat vibriosis. Bacterial inactivation is more efficient and occurs earlier when 
the phage cocktails are used, but their use in vitro does not prevent bacterial 
regrowth after treatment. However, the use of phage cocktails retarded the 
regrowth of the bacteria. The application of phages with lysozyme to eliminate 
or reduce fish pathogenic bacteria in aquaculture can be a promising strategy, 
namely when less effective phages are available. Besides, the use of phages 
with a high burst size and a short latent period clearly increase the efficiency 
of phage therapy. 
 
i 
 
Table of contents 
 
Table of contents .................................................................................................................... i 
List of figures ........................................................................................................................ v 
List of tables ......................................................................................................................... ix 
Acronyms and Abbreviations ............................................................................................... xi 
 
Chapter 1: Introduction ..................................................................................................... 1 
1.1 Bacteriophages ............................................................................................................. 1 
1.1.1 Discovery of bacteriophages ................................................................................. 1 
1.1.2 Bacteriophages morphology .................................................................................. 2 
1.1.3 Taxonomy of bacteriophages ................................................................................ 3 
1.2.4 The phage life cycle .............................................................................................. 5 
1.2.5 Effect of lysins on phage activity .......................................................................... 8 
1.2 Aquaculture ................................................................................................................ 10 
1.2.1 Fish farming diseases .......................................................................................... 11 
1.2.2 Disease prevention in fish farms ......................................................................... 14 
1.2.3 Resistance to antibiotics ...................................................................................... 15 
1.2.3.1 The use of antibiotics in aquaculture and the associated risks for human 
medicine ................................................................................................................... 19 
1.3 Phage therapy: an alternative to antibiotics ............................................................... 22 
1.3.1 Application of phage therapy in aquaculture ...................................................... 22 
1.4 Advantages of phage therapy over chemotherapy in fish farms ................................ 25 
1.4.1 Phage cocktails in the treatment of bacterial infections ...................................... 26 
1.5 Objectives of the work ............................................................................................... 29 
 
Chapter 2: Efficiency of phage cocktails in the inactivation of Vibrio in aquaculture ... 43 
Abstract ............................................................................................................................ 43 
Introduction ...................................................................................................................... 44 
Materials and methods ..................................................................................................... 46 
iii 
 
Results .............................................................................................................................. 49 
Discussion ........................................................................................................................ 57 
Conclusion ....................................................................................................................... 60 
References ........................................................................................................................ 61 
 
Chapter 3: Effect of lysozyme addition on the activity of phages against Vibrio 
parahaemolyticus ................................................................................................................ 67 
Abstract ............................................................................................................................ 67 
Introduction ...................................................................................................................... 68 
Materials and methods ..................................................................................................... 70 
Results .............................................................................................................................. 73 
Discussion ........................................................................................................................ 80 
References ........................................................................................................................ 83 
 
Chapter 4: Conclusions and future perspectives ............................................................. 89 
 
v 
 
List of figures 
 
Figure 1.1 - Schematic representation of a typical bacteriophage (adapted from Hanlon, 
2007)............................................................................................................................... 3 
Figure 1.2 - Schematic representation of the morphology of bacteriophages (adapted from 
Ackermann, 2003). ......................................................................................................... 5 
Figure 1.3 - Bacteriophages lytic and lysogenic cycles (adapted from Hogg, 2005). .......... 7 
Figure 2.1 - Inactivation of V. parahaemolyticus by the three phages (VP-1, VP-2 and VP-
3) at a MOI of 100 during the 24 h of the experiments. A. Bacterial concentration: BC 
– Bacteria control; BP – Bacteria plus phage. B. Phage concentration: PC – Phage 
control; BP – Bacteria plus phage. Values represent the mean of three experiments; 
error bars represent the standard deviation. ................................................................. 52 
Figure 2.2 - Inactivation of V. parahaemolyticus by phage cocktails at a MOI 100 during 
the 24 h of the experiment. A. bacterial concentration: BC – Bacteria control; BP – 
Bacteria plus phage. B. Phage concentration: PC – Phage control; BP – Bacteria plus 
phage. VP-1 – phage VP-1; VP-2 – phage VP-2, VP-3 – phage VP-3. Values represent 
the mean of three experiments; error bars represent the standard deviation. ............... 54 
Figure 2.3 - VP-1, VP-2 and VP-3 phage survival in aquaculture marine water. Values 
represent the mean of three experiments; error bars represent the standard deviation. 56 
Figure 2.4 - VP-1, VP-2 and VP-3 phage one-step growth experiments in the presence of 
V. parahaemolyticus as host. Values represent the mean of three experiments; error 
bars represent the standard deviation. .......................................................................... 57 
Figure 3.1 - Inactivation of V. parahaemolyticus by the VP-2 phage and by the VP-2 
phage with lysozyme (0,8 µg mL-1 and 1,6 ug mL-1) at a MOI of 100 during the 24 h 
of the experiment. A. bacterial concentration: BC – Bacteria control; BCL – Bacteria 
plus lysozyme. B. Phage concentration: PC – Phage control; PCL – Phage control with 
lysozyme; BP - Bacteria plus phage; BPL – Bacteria plus phage and lysozyme. Values 
represent the mean of three independent experiments; error bars indicate the standard 
deviation. ...................................................................................................................... 75 
vii 
 
Figure 3.2 - Inactivation of V. parahaemolyticus by the VP-1 phage alone and by the VP-1 
phage in the presence of lysozyme (10 mg mL-1) at a MOI of 100 during the 24 h of 
the experiment. A. bacterial concentration: BC – Bacteria control; BCL – Bacteria 
plus lysozyme. B. Phage concentration: PC – Phage control; PCL – Phage control with 
lysozyme; BP - Bacteria plus phage; BPL – Bacteria plus phage and lysozyme. Values 
represent the mean of three independent experiments; error bars indicate the standard 
deviation. ...................................................................................................................... 76 
Figure 3.3 - Inactivation of V. parahaemolyticus by the VP-2 phage alone and by the VP-2 
phage in the presence of lysozyme (10 mg mL-1) at a MOI of 100 during the 24 h of 
the experiment. A. bacterial concentration: BC – Bacteria control; BCL – Bacteria 
plus lysozyme. B. Phage concentration: PC – Phage control; PCL – Phage control with 
lysozyme; BP - Bacteria plus phage; BPL – Bacteria plus phage and lysozyme. Values 
represent the mean of three independent experiments; error bars indicate the standard 
deviation. ...................................................................................................................... 78 
Figure 3.4 - Inactivation of V. parahaemolyticus by the VP-3 phage alone and by the VP-3 
phage in the presence of lysozyme (3 mg mL-1, 10 mg mL-1 and 20 mg mL-1) at a MOI 
of 100 during the 24 h of the experiment. A. bacterial concentration: BC – Bacteria 
control; BCL – Bacteria plus lysozyme. B. Phage concentration: PC – Phage control; 
PCL – Phage control with lysozyme; BP - Bacteria plus phage; BPL – Bacteria plus 
phage and lysozyme. Values represent the mean of three independent experiments; 
error bars indicate the standard deviation. ................................................................... 80 
 
 
ix 
 
List of tables 
 
Table 1.1 - Basic properties of phage families (adapted from Ackermann, 2003). .............. 4 
Table 1.2 - Classes of antibiotics used in aquaculture, their importance for human 
medicine and examples of (multi)resistant pathogenic bacteria isolated from 
aquaculture (adapted from Defoirdt, et al., 2011). ....................................................... 17 
Table 2.1- Efficiency of plating (%) to different bacteria. ................................................. 50 
Table 3.1- Efficiency of plating (%) of different bacteria. ................................................. 73 
 
 
 xi 
 
Acronyms and Abbreviations 
 
ANOVA Analysis of variance 
CFU Colony forming units 
CFU mL-1 Colony forming units per milliliter 
CWBD C-terminal cell wall binding domain 
ds Double-stranded 
HACCP Hazard Analysis and Critical Control Points 
ICTV International Committee for taxonomy 
LPS Lipopolysaccharide 
MOI Multiplicity of infection 
PFU Plaque forming units 
PFU mL-1 Plaque forming units per milliliter 
PG Peptidoglycan 
SAR Signal arrest release 
ss Single-stranded 
VNN Viral nervous necrosis 
TSA Tryptone Soy Agar 
TSB Tryptic Soy Broth 
WHO World Health Organization 
  
  
  
  
  
  
  
 1 
 
Chapter 1: Introduction 
 
1.1 Bacteriophages 
 
1.1.1 Discovery of bacteriophages 
 
Bacteriophages, or simply phages, are viruses that have the ability to infect bacteria, 
and, in the case of lytic phages, cause lysis of the bacteria leading to their subsequent death 
(Sulakvelidze, et al., 2001). These form the largest group of all viruses, and have the 
ability to colonize every habitat conceivable in nature and can be found in large quantities. 
The group where the bacteriophages are found is quite diverse, being indisputably the 
oldest one (Ackermann, 2001, Ackermann, 2007). They exist in high concentrations in 
natural environments, it is estimated that the presence of bacteriophages in the world is 
1031, which is equivalent to about 109 tones, making them the most abundant viruses the 
on earth (Kropinski, 2006, Hanlon, 2007). 
The discovery of these viruses is involved in a great controversy because, in 1896, 
Ernest Hanking, a british bacteriologist, noted the presence of an unidentified substance in 
the waters of an indian river. That substance limited the spread of cholera epidemics. Two 
years later, a russian bacteriologist, Nikolay Gamaleya, observed a similar phenomenon 
while working with Bacillus subtilis. About twenty years after the observations of Ernest 
Hanking, a medically trained english bacteriologist named Frederick Twort, reported 
something similar and put forward the possibility that the observed results could be due to 
a virus. For various reasons, such as financial ones, the bacteriologist Twort failed to 
pursue his investigations (Kropinski, 2006, Hanlon, 2007). In 1917, Felix d'Herelle, a 
franco-canadian microbiologist, officially discovered the bacteriophages. During his 
studies, d'Herelle filtered fecal samples of several patients, mixed and incubated it with 
Shigella strains isolated from the patients. A portion of this mixture was placed in 
experimental animals, due to the fact that part of his study of focused on the development 
of a vaccine against bacterial dysentery. The other part of the mixture was plated in agar 
medium in order to observe bacterial growth. After incubation, d'Herelle noted the 
appearance of white spots, that he gave the name of plates. After his observation he was 
convinced that the invisible microbes responsible for that plates were viruses and that they 
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were able to multiply indefinitely causing the lysis of bacteria that are necessary for their 
survival (Sulakvelidze, et al., 2001). After the discovery of bacteriophages, d`Herelle 
introduced the term phage therapy, that was regarded as a possible method of treatment 
against bacterial infectious diseases (Karen, 2001, Sulakvelidze, et al., 2001). This method 
of treatment was used to treat and prevent bacterial infection diseases in the former Soviet 
Union and Eastern Europe, however, was abandoned by the West in the 1940 with the 
appearance of the antibiotics (Chanishvili, et al., 2001, Matsuzaki, et al., 2005). The 
emergence of pathogenic bacteria resistant to antibiotics, including multirresistant bacteria, 
has recently motivated the western scientific community to revaluate phage therapy as a 
valid option for the treatment of bacterial infections (Krylov, 2001, Gill & Hyman, 2010). 
Currently, beyond phage therapy of humans pathogenic bacteria, phage therapy is also 
being studied as a treatment for animals and plant diseases caused by bacteria, and is 
already used as a means of controlling both human pathogenic and spoilage bacteria in 
foods (Balogh, et al., 2010, Gill & Hyman, 2010, Kutter, et al., 2010). 
 
1.1.2 Bacteriophages morphology 
 
In morphological terms, the bacteriophages may have different sizes and shapes, but 
mostly of them exhibit a capsid, collar and tail. (Figure 1.1) (Hanlon, 2007). The head (or 
capsid) is a protein shell often in the shape of an icosahedron and usually comprises 
double-strand (ds) DNA. The capsid is organized into capsomeres, whose main function is 
to protect the genetic material (Ackermann, 2001, Goodridge & Abedon, 2003, Hanlon, 
2007). The capsid has three important functions during the phage life cycle: (1) protect the 
phage genome during its extracellular phase, (2) enable the adsorption of the phage, fixing 
the virus to the host bacterium (in Caudovirales), and (3) the subsequent delivery of the 
phage genome into the host cytoplasm (Goodridge & Abedon, 2003). The phage genome 
can vary between 17 kb and 500 kb. However, despite the size of the phage genome, it 
doesn’t have the necessary machinery for the production of energy and doesn’t also have 
ribosomes for protein synthesis (Goodridge & Abedon, 2003). Regarding the tail, six fibers 
are usually linked to the tail, containing receptors on their ends that recognize binding sites 
on the surface of the bacterial cell. However, not all phages have tails and tail fibers and in 
this situation there are other attachment mechanisms (Goodridge & Abedon, 2003, Hanlon, 
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2007). Phages without a tail, like the MS2 phage, only infect bacterial cells that contain a 
certain type of plasmid, called the conjugative plasmid, which allows the bacterial cell to 
function as a donor in conjugation. This is because these viruses infect bacteria by first 
attaching to the pili (Madigan, 2011). 
 
 
 
Figure 1.1 - Schematic representation of a typical bacteriophage (adapted from Hanlon, 2007). 
 
1.1.3 Taxonomy of bacteriophages 
 
The International Committee for Taxonomy of Viruses (ICTV) is presently 
responsible for the classification of the viruses (Ackermann, 2003). 
The taxonomic classification of bacteriophages takes into account their size and 
shape as well as their type of nucleic acid (Table 1.1 and Figure 1.2). The dsDNA phages 
with tail are classified in the Caudovirales order. These bacteriophages belong to the 
Caudovirales order, based on the bacteriophage tail structure, are divided into three 
families: (1) Moyviridae , in which viruses have a contractile tail constituted by a hem and 
a central tube, (2) Siphoviridae, in which viruses have long not contractible tails, and (3) 
Podoviridae, in which viruses have no contractile and short tails (Ackermann, 2003, 
Ackermann, 2007, Drulis-Kawa, et al., 2012). The other non-tailed phages, are classified 
into ten families (Table 1.1), and are cubic, filamentous, or pleomorphic and contain 
double-stranded or single stranded DNA or RNA as the genome (Ackermann, 2007).  
Although it was assumed that most of the viruses in seawater contain DNA and 
infect bacteria, presently it is known that the abundance of RNA containing viruses in the 
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ocean, which almost exclusively infect eukaryotes, rivaled or even exceeded that of DNA 
viruses in samples of coastal seawater. It has been recently discovered new single-stranded 
RNA (ssRNA) viruses, that infect marine protists, which are classified as members of the 
order Picornavirales. A new genus in the family Reoviridae has also been reported as a 
double-stranded RNA virus that infect the abundant marine prymnesiophyte Micromonas 
pusilla (Steward, et al., 2013). 
 
Table 1.1 Basic properties of phage families (adapted from Ackermann, 2003). 
 
Legend: C, circular; L, linear; S, segmented; T, superhelical; 1, single-stranded; 2, double-stranded. 
 
 
Shape Family Nucleic acid Characteristics Example 
Tailed Myoviridae DNA, ds, L Contractile tail T4 
 
 Siphoviridae 
 
DNA, ds, L Long, noncontractile 
tail 
λ 
 
 Podoviridae DNA, ds, L Short tail T7 
Polyhedral Microviridae DNA, ss, C  φX174 
 Corticoviridae               ds, C, T Complex capsid, 
lipids 
PM2 
 Tectiviridae         ds,L Internal lipoprotein 
vesicle 
PRD1 
 Leviviridae RNA, ss, L  MS2 
 Cystoviridae               ds, L, S Envelope, lipids φ6 
Filamentous Inoviridae DNA, ss, C Filaments or rods Fd 
 Lipothrixviridae           ds, L Envelope, lipids TTV1 
 Rudiviridae           ds, L Resembles TMV SIRV1 
Pleomorphic Plasmaviridae DNA, ds, C, T Envelope, lipids, no 
capsid 
L2 
 Fuselloviridae           ds, C, T Spindle-shaped, no 
capsid 
SSV1 
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Figure 1.2 - Schematic representation of the morphology of bacteriophages (adapted from Ackermann, 2003). 
 
1.2.4 The phage life cycle 
 
There are two important ways in which viruses interact with their hosts: the infection 
cycle with a lytic pathway and the lysogenic infection cycle (Lenski, 1988, Hanlon, 2007). 
In the lytic cycle, as shown in Figure 1.3 the phage injects its genome into the host cell 
(Hogg, 2005). To multiply itself, the phage needs to cause lysis of the host cell to release 
the newly formed phages (Skurnik & Strauch, 2006). The viruses find their host by the 
presence of cell surface components, or, in some cases, binding sites may be present in the 
cell capsule, flagella, or even pili, allowing the recognition and following attachment 
(Fischetti, 2005, Hanlon, 2007). At the beginning, this connection is made randomly and is 
reversible, but later becomes irreversible and is followed by the transfer of the phage 
genetic material to the host cell. The injection of the phage genome into a bacterial cell can 
occur by a variety of mechanisms (depending on the morphology of the viruses), but often 
involves the contraction of the tail and formation of a hole inside the bacterial cell wall. 
The bases of the phage DNA are often modified to protect against the attack by restriction 
enzymes and cellular nucleases. The viral genome is transcribed by RNA polymerases of 
the host cell, producing premature mRNA. The premature mRNA function is to take over 
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the metabolic machinery of the bacterium and redirect the metabolic processes to the 
manufacture of new viral components (Hanlon, 2007).  
After the replication and assembly of new phage particles within the host cell, the 
new phages are released to the environment (Hanlon, 2007). Almost all of the dsDNA 
phages develop enzymes that attack the bacterial peptidoglycan, like lysozymes that act at 
the sugar links, endopeptidases that break peptide bonds or amidases that act on amide 
links (Fischetti, 2005). These lytic enzymes (usually called muralytic enzymes or 
endolysins), coded by the phage genome, are produced within the cytoplasm but require 
another enzyme to allow them to cross the cytoplasmic membrane to reach its substrate. 
This enzyme is a holin that ruptures the membrane, allowing the lysin to degrade the 
peptidoglycan (Young, et al., 2000, Fischetti, 2005). The holin controls the timing of the 
cell lysis and the release of the phage progeny. The filamentous phage can escape the host 
cell by extrusion through the cell wall without causing the destruction of the host, these 
phages did not present relevance for phage therapy (Hanlon, 2007). The period of time 
between the attachment of a phage particle to the cell surface and the release of the newly 
synthesized phages is called the latent period, sometimes also known as the burst time 
(Hogg, 2005). 
Temperate phages are viruses that don’t enter automatically on a lytic cycle, the 
phage genome will integrate the genome of the host cell (Figure 1.3). By being included in 
the host genome, the genetic material of the phage will be replicated together with the 
genome of the bacteria, remaining in a dormant state as a prophage for long periods of time 
(Figure 1.3) (Hogg, 2005, Skurnik & Strauch, 2006). The temperate phages induce a state 
of lysogeny in the bacterial host (Hanlon, 2007).  
Cells can undergo multiple rounds of division but, occasionally, one will 
spontaneously lyse and release progeny phage. Alternatively, a population of lysogenic 
cells can be induced to lyses by submitting them to stress and treatment with mutagens or 
by exposure to ultraviolet light. A few temperate phages, such as Mu, can switch between 
lysogeny and lytic growth under the influence of elevated temperatures in the host 
stationary phase (Ranquet, et al., 2005). The prophage directs the synthesis of a repressor 
protein which blocks the transcription of its own genes and also those of closely related 
bacteriophages. The presence of a prophage may therefore confer a certain type of bacterial 
cell immunity to other infections by phages. Lysogenic bacteria may have other 
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advantages, in terms of acquisition of genes that confer increased virulence or 
pathogenicity. When one prophage escapes regulation by the repressor, its DNA is cut free 
inducing a lytic cycle. But, excision of the prophage DNA is often imprecise and bacterial 
genes adjacent to the prophage DNA may be incorporated into infectious phage DNA and 
then transferred into host cells. This process is called transduction, and is responsible for 
the horizontal transfer of genes from one bacterial cell to another. Examples of virulence 
genes include those used for host attachment, invasion and survival, as well as for the 
production of toxins. Temperate phages are not suitable candidates for phage therapy since 
they can’t immediately destroy the host bacteria (Brüssow, et al., 2004, Hanlon, 2007). 
 
 
 
Figure 1.3 - Bacteriophages lytic and lysogenic cycles (adapted from Hogg, 2005). 
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1.2.5 Effect of lysins on phage activity 
 
The phages can use two forms to release the new viral particles from the bacterial 
hosts. In filamentous phages, the progeny is unceasingly extruded from the bacterial cells 
without harming the bacteria, through the use of phage encoded specific enzymes that 
interfere with host enzymes that are responsible for peptidoglycan synthesis (García, et al., 
2010), while non-filamentous phages breakdown the host cell wall by phage encoded lytic 
enzymes (Hermoso, et al., 2007, García, et al., 2010).  
The lytic enzymes (also called endolysins or lysins) used to destroy the bacterial cell 
wall are enzymes that are encoded by the phage genome, and are produced during the late 
phase in the lytic cycle to degrade the bacterial cell wall, and act on the cell wall from 
inside the cell facilitating the release of the virions (Hogg, 2005, Hermoso, et al., 2007, 
Drulis-Kawa, et al., 2012). The lytic enzymes used to infect the cell are components of the 
virion tail that are able to locally digest the cell wall from the outside to facilitate the 
injection of the phage genome into the host cell (Hogg, 2005, Hermoso, et al., 2007). This 
kind of lytic enzymes are widespread in the virions of phages infecting Gram-positive or 
Gram-negative bacteria (Hermoso, et al., 2007). A classic example is the T4 phage 
lysozyme that is inserted into a baseplate protein of the tail tube, at the tip of the tube 
(Hermoso, et al., 2007).  
Lysins can be classified according to their catalytic activity as lysozymes or 
muramidases, glucosaminidases, N-acetylmuramoyl-L-alanine-amidases (NAM-amidases), 
endopeptidases and lytic transglycosylases. Glucosaminidases, lysozymes and lytic 
transglycosylases act on the sugar moiety (glycosidases), whereas endopeptidases cleave 
the peptide cross-bridge and NAM-amidases hydrolyze the amide bond connecting the 
sugar and peptide constituents of peptidoglycan (Moak & Molineux, 2004, Hermoso, et al., 
2007, García, et al., 2010). These lytic enzymes, namely lysozymes, are also produced by 
other eukaryotic and prokaryotic organisms, being involved in non-specific defence 
mechanisms (Burge, et al., 2007). Muramidases and amidases that hydrolyze the most 
conserved bonds in the peptidoglycan appear to be the most widely spread (Fischetti, 
2008). 
Normally, lysins have no signal peptide, accessing to the peptidoglycan of the cell 
through the use of small hydrophobic protein, denominated holin, allowing the lysins to 
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cross the cytoplasmic membrane and gain access to the cell wall (Loessner, 2005, 
Borysowski, et al., 2006, Hermoso, et al., 2007). However, a few number of lytic enzymes 
contain signal peptides that are recognized by the host general secretion pathway (García, 
et al., 2010). In this case, a typical host sec system is used to reach the peptydoglican. 
Some lysins that are exported by the host sec system comprehend N-terminal signal 
sequences that function as a type II signal anchor or uncleaved signal peptide. This signal 
sequence has been nominated signal arrest release (SAR) sequence because of the ability 
of the protein to escape from the membrane and posterior release into the periplasm 
(Hermoso, et al., 2007).  
Phage lysins can also be classified according to their structure as globular or modular 
composed. The globular structure is built of a single catalytic domain and the modular 
structure is composed by two domains: N-terminal catalytic domain (CD), and C-terminal 
cell wall binding domain (CWBD), or three domains (with an additional mid protein 
domain with enzymatic activities). Normally, lysins from Gram-negative specific phages 
are characterized by a globular structure, single module structure, whereas an additional 
substrate-binding domain is typical of Gram-positive specific phages. Depending on the 
type of the targeted bond in the peptidoglycan CD cab, they exhibit different enzymatic 
activities. The C-terminal cell wall binding domain (CWBD) confers some degree of 
specificity to the enzymes (Drulis-Kawa, et al., 2012).  
The capacity of purified lysins as recombinant proteins to kill bacteria was first 
reported in 1959. Since then, research on phage lysins has highly evolved (Drulis-Kawa, et 
al., 2012). However, only recently these enzymes were recognized as specific and potent 
antibacterial agents when added exogenously (Hermoso, et al., 2007, Díez-Martínez, et al., 
2013). Although these enzymes, with high lytic activity, have been recognized for nearly a 
century, their use in a purified form did not receive much attention. However, with the 
advent of antibiotic-resistant pathogenic bacteria has sparked renewed interest and is now 
well established that these lysins, when added to bacteria in absence of bacteriophage, are 
able to irreversibly damage the bacterial cell wall (Hermoso, et al., 2007, Díez-Martínez, et 
al., 2013). 
The phage lysins show numerous advantages when compared with the antibiotics: (1) 
hight specificity, they are usually specific to a species or subspecies (Hermoso, et al., 
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2007), (2) low toxicity, (3) low probability of resistance development, and, (4) high 
efficiency (Drulis-Kawa, et al., 2012). 
Although lysins are generally strain specific, there are some cases of phage lysins 
with broad spectrum of lytic activity, for example the lysins PlyV12 and PlySs2 from  
bacteriophages of Enterococcus faecalis and Streptococcus suis, respectively (Díez-
Martínez, et al., 2013). Lysins encoded by Gram-negative specific phages normally exhibit 
a broad spectrum and are generally amidases. Several globular Gram-negative phage 
endolysins exhibiting broad spectrum activity have been described. Besides, endolysins 
exhibiting a broad spectrum may also be characteristic of some Gram-positive phages 
which encode amidase and non-amidase murein hydrolases (Drulis-Kawa, et al., 2012). 
 
1.2 Aquaculture 
 
Aquaculture is the cultivation of aquatic populations, including fish, molluscs, 
crustaceans and plants, by individuals, groups or corporations that, under controlled 
conditions, such as controlled breeding, confinement, supplying nutrients and medicines, 
aim to increase their production (Sapkota, et al., 2008). This form of culture of aquatic 
animals and plants exists in environments of fresh, brackish and marine water, either in 
open or closed systems (Pillay & Kutty, 2005). 
The most frequent forms of aquaculture are open net pens or cages in offshore areas 
and ponds and tanks in coastal or inland waters (Almeida, et al., 2009). The offshore 
aquaculture is often used to cultivate salmon, seabream, seabass, shrimp, catfish, trout, 
abalone, oysters and seaweed (Almeida, et al., 2009, Menicou & Vassiliou, 2010). 
Although more slowly than in the 1980s and 1990s, aquaculture production 
continues to grow in the new millennium, not only in terms of production but as a 
technological innovation to meet the demands of a growing world population. In 2010, 
world aquaculture production hit another high record of 60 million tons of fish. However, 
despite the growth in the international sector, the industry now faces some challenges to 
socio-economic, environmental and technological conditions. For example, the marine 
cage culture of Atlantic salmon in Chile, the oyster farming in Europe (particularly in 
France) and the marine shrimp farming in most countries of Asia, South America and 
Africa, had high mortality rates caused by disease outbreaks in recent years, resulting in 
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partial or sometimes total loss of production. Water pollution has increasingly threatened 
the production in some newly industrialized and rapidly urbanizing areas. In 2010, 
aquaculture in China suffered production losses of 1.7 million tons caused by diseases (295 
000 tons), natural disasters (1.2 million tons) and pollution (123 000 tons). In 2011, disease 
outbreaks virtually eliminated the production of marine shrimp farming in Mozambique 
(FAO, 2012). 
Microbial infections, namely bacterial infection, are the major concern in the 
aquaculture industry, leading to large financial losses endangering the sustainability of the 
sector (Almeida, et al., 2009). The problem increases due to the emergence of multidrug 
resistant bacteria that infect a wide variety of fish (Almeida, et al., 2009, Oliveira, et al., 
2012).  
For these reasons, it is necessary and urgent to find new alternatives for effective 
control and treatment of microbial infections in aquaculture environments. Phage therapy 
is a promising new approach that can be used to reduce the impact of bacterial infections in 
aquaculture systems. 
 
1.2.1 Fish farming diseases  
 
Diseases are commonly found in farm fishes. The unfavorable conditions found in 
fish farms, such as the great density of fishes, increases the possibility of transference of 
pathogens between individuals. Due to high temperatures, rapid growth and overfeeding in 
fish cultivation, the conditions can become disadvantageous. With the accumulation of 
residues, a source of feeding for microorganisms, the risk of diseases outbreaks increases. 
Furthermore, when sick and dead fish are not extracted from the farming area in proper 
time, the risk of disease is higher, giving the opportunity to pathogens to become more 
aggressive when the environment is polluted. It was already been shown that pathogenic 
microorganisms are not introduced into the aquatic environment by farmed fish, although, 
it has been suggested that wild fish are a significant source of pathogenic microorganisms. 
Although the occurrence of sick individuals in wild stocks is generally low, the number of 
infected fish might be high, due to the fact that the individuals can be infected without 
exhibiting evident signs of disease (Weiss, 2002). 
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The main biological agents that cause waterborne diseases include bacteria, viruses, 
protists, helminths, oomycetes and fungi, however, various fish farming plants often suffer 
from heavy losses owing to frequent infections essentially caused by bacteria (Alderman, 
1996, Wahli, et al., 2002). 
In terms of public health there are two groups of bacteria that infect fish with 
increased importance to the indigenous microflora (those naturally present in the 
environment) such as Photobacterium damselae, Vibrio anguillarum, Vibrio vulnificus, 
Aeromonas hydrophila, Aeromonas salmonicida, and non-indigenous microflora (those 
introduced by environmental contamination by excrement of domestic animals and/or 
human waste), like Enterobactereaceae such as Salmonella sp. and Escherichia coli 
(Muroga, et al., 1986, Huss, 1994, Nakai & Park, 2002). 
Although a large number of bacteria cannot survive in environmental water and 
eventually die, a large number of these remains on the skin and in the gut of the fish being 
a risk to consumers health (Almeida, et al., 2009).  
The main diseases of marine and estuarine fish worldwide are vibriosis and 
photobacteriosis (formerly called pasteurellosis), both in natural production systems as 
well as in commercial ones, occurring only occasionally in freshwater fishes. Vibriosis and 
photobacteriosis diseases are responsible for major outbreaks in fish farm plants, reaching 
values of up to 100 % in the infected structures. Photobacteriosis and vibriosis are caused 
by bacteria of the Vibrionaceae family. Vibriosis is caused by species of Photobacterium 
(including Photobacterium damselae subsp. Damselae, formerly Vibrio damselae) and 
Vibrio (including V. anguillarum, V. vulnificus, V. alfinolyticus, V. parahaemolyticus and 
V. salmonicida). Photobacteriosis is caused by P. damselae subsp. Piscicida (formerly 
Pasteurella piscicida) which is a highly pathogenic bacterium that does not seem to have 
host specificity, infecting a wide range of fish species (Toranzo, et al., 1991, Noya, et al., 
1995). In many countries of the Mediterranean such as France, Italy, Spain, Greece, 
Portugal, Turkey, Malta, Israel and Croatia, this pathogen causes high mortality rates in 
populations of seabass (Dicentrarchus labrax) and seabream (Sparus aurata) (Thyssen & 
Ollevier, 2001). Photobacteriosis continues to be a severe problem in intensive culture of 
different fish species in the Mediterranean area and Japan. Vibrionaceae species are also 
known to cause disease in humans and are mostly associated with the consumption of 
contaminated fish aquaculture. Rickettsia, A. salmonicida (causative agent of furunculosis) 
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and Edwardsiella tarda are also a significant group of fish pathogens, affecting a variety of 
fish species (Nakatsugawa, 1983, Mekuchi, et al., 1995, Fryer & Lannan, 1996, Bernoth, 
1997). 
Viral diseases can also cause great losses in marine aquaculture (Munn, 2006, 
Saksida, et al., 2006), however, the risk of infection in humans by the consumption of 
contaminated fish is low, because the viruses that cause diseases in fish are not pathogenic 
to humans (Almeida, et al., 2009). Viruses that infect commercial fishes can be included in 
a variety of viral families, such as Irodovirus, Rhabdovirus, Birnavirus, Nodavirus, 
Reovirus, and Herpesviruses (Muroga, 2001, Suttle, 2007). The wide host range of these 
viruses and their ability to move between marine and fresh water, makes them a serious 
threat, allowing their spread into new areas (Meyers, et al., 1999, Skall, et al., 2005). 
Iridovirus has been identified as one of the most important pathogens, infecting more than 
30 grouper species in the last decade (Wang & Wu, 2007). The viral nervous necrosis 
(VNN) disease caused by nervous necrosis virus is one important viral disease that causes 
mass mortality in more than 39 marine fish species of 10 families (Harikrishnan, et al., 
2011, Ma, et al., 2012). 
In respect to parasites, the main problem regarding food security focuses on a limited 
number of helminth species, and the risks are largely focused on communities where the 
consumption of raw or undercooked fish is a cultural habit. The main diseases 
transmittable to humans by the consumption of parasite contaminated fishes are 
trematodiasis, cestodiasis and nematodiasis. In addition to the hazards related to food 
safety, the parasites are also a concern in aquaculture because they often cause damage to 
the fish tissues, creating an ideal place to get a bacterial infection (Almeida, et al., 2009). 
In freshwater aquaculture, oomycetas are the second leading cause of infection in 
fish, after bacteria. Oomycetas may affect eggs, fingerlings and adult fishes when they are 
mechanically damaged or with infections caused by other pathogens (Ogbonna & Alabi, 
1991, Gieseker, et al., 2006). Saprolegnia parasitica is a very important fish pathogen, 
especially of catfish, salmon and trout species (Almeida, et al., 2009). Cryptocaryon 
irritans is a parasite of commercial fishes (like grouper, for example) that is receiving 
worldwide attention. Besides the wide range of hosts, this parasite invades the skin, eyes 
and gills and causes the white spot disease in marine fish and is considered to be one of the 
most devastating parasite of marine fish (Harikrishnan, et al., 2010). 
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1.2.2 Disease prevention in fish farms 
 
A sustainable prevention of aquaculture diseases is desirable in health management, 
however, it is not always economically possible to supply optimal conditions and feeding 
ideal. The rapid spread and the ubiquitous nature of fish pathogenic microorganisms means 
that the prevention and control of infections is difficult (Almeida, et al., 2009). 
Vaccination would be the ideal method for the prevention of infectious diseases, 
however, the available vaccines in aquaculture are still very limited, and it is unknown 
whether vaccinated or disease resistant fish are able to clear viral pathogens when infected 
or are carrying it (Almeida, et al., 2009, Johansen, et al., 2011). 
The vaccination basically works on the assumption that there is an immunological 
memory and that prior exposure to a pathogen allows a faster and stronger immune 
response (Lucas & Southgate, 2012). The success of vaccine development has been 
protecting the fishes against disease outbreaks and, in some cases, prevents or reduces the 
spread of pathogens from farmed to wild fish (Johansen, et al., 2011). 
Pasteurelosis and vibriosis have been largely controlled by the use of vaccines (Press 
& Lillehaug, 1995, Romalde, 2002). A vaccine against Vibrio spp. was effective in 
European Salmonid especially when administered by injection. Prophylactic immunization 
for other bacterial diseases in farmed fish has been tried with some success against 
Aeromonas salmonicida and Yersinia ruckeri (Press & Lillehaug, 1995). Vaccinated fish 
seem to grow and survive better than their unvaccinated counterparts, however, the exact 
nature of the immunity provided is unclear (Reed & Francis-Floyd, 1996). Despite some 
demonstrated successes, not all vaccines are effective enough and, for many pathogens, 
there are no available vaccines yet. For example, it is difficult to develop effective vaccines 
against intracellular bacteria (Johansen, et al., 2011) and the vaccines in the field of 
aquaculture are still limited (Reed & Francis-Floyd, 1996., Romalde, 2002, Arijo, et al., 
2005, Lin, et al., 2006). In addition, vaccination is not possible in the case of fish larvae, 
which are generally more susceptible to disease, since it is virtually impractical to deal 
with these small animals and because it is believed that the fish larvae do not have the 
ability to develop specific immunity (Vadstein, 1997, Almeida, et al., 2009). 
The development of vaccines for fish viral diseases, has been unsuccessful for a long 
period. Viral vaccines were developed for two viral diseases caused by the infectious 
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pancreatic necrosis virus and the infectious hematopoietic necrosis virus and a recombinant 
DNA-based vaccine was developed for the treatment of infectious pancreatic necrosis virus 
(Christie, 1997). However, these vaccines produced unsatisfactory results because the 
residual virulence killed the target species. In order to prevent the transmission of diseases 
and pathogens, it is necessary to understand the host-pathogen interactions and cell-
mediated immune responses in fish (Johansen, et al., 2011). 
The prevention and control of diseases in aquaculture becomes even more difficult 
due to several factors such as: (1) high levels of fecal contamination in fish farms water 
(poor water quality) (Huss, 1994, Howgate, et al., 1997, Almeida, 2009); (2) irregular 
environmental conditions (i. e., elevated temperatures, salinity changes, decreased oxygen 
concentrations, high organic loads), factors that may contribute for the appearance of 
diseases, often weakened by the innate fish defense systems (Defoirdt, et al., 2007); (3) 
high densities (greater than what is indicated for each species) commonly used in fish 
farming systems, which reduce the resistance to infection (Defoirdt, et al., 2007); (4) 
different stages of the fish life cycle, which increases the occurrence of infections 
(Defoirdt, et al., 2007); (5) the indiscriminate use of antibiotics increased resistance 
problems in common pathogenic bacteria and increased the concern with the spread of 
antibiotics in the environment (Defoirdt, et al., 2007); (6) several chemotherapeutic agents 
that are effective against bacteria and oomycetes have low activity against endospores and 
zoospores (Alderman, 1999); (7) a significant number of pathogenic spores remain on the 
fish skin, even after quarantine (Alderman, 1999), and (8) few medications are licensed for 
use in fisheries (Kusuda & Kawai, 1998, Muroga, 2001). 
 
1.2.3 Resistance to antibiotics 
 
Although antibiotics were a viable and effective method for the treatment of diseases 
caused by pathogenic bacteria their indiscriminate and frequent use resulted in the 
development and spread of antibiotic resistance leads to ineffective treatment of bacterial 
infections (Defoirdt, et al., 2011). 
The problem of antibiotic resistance becomes even more serious due to the fact that 
the spread of antimicrobial resistance is not necessarily restricted by phylogenetic, 
geographical and ecological borders. For this reason, the use of antibiotics in an ecological 
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niche, such as aquaculture, can lead to the occurrence of antimicrobial resistance in other 
ecological niches, including the human environment, making resistance to antibiotics a 
problem of public health concern (Heuer, et al., 2009). 
In marine environment, over 90% of the bacterial strains are resistant to more than 
one antibiotic, and 20% are resistant to at least five antibiotics (Martinez, 2003). The 
antibiotics are frequently ineffective in diseases treatments and a possible reason might be 
the fast replication of microorganisms that can induce quick mutations (Almeida, et al., 
2009). This possibility of mutation rapidly becomes prevalent throughout the microbial 
population, which helps the microbes to survive, for example in the presence of an 
antibiotic (Martinez, 2003). In aquaculture, the two most common via of antimicrobials 
administration are through the use of medicated feed or by the addition of antimicrobial 
agents directly into the water (immersion therapy) (Heuer, et al., 2009).  
The main problems in aquaculture systems of intensive and semi-intensive 
production arise from the regular use of artificial foods supplemented with antibiotics, in 
order to prevent the spread of diseases, which results in the development of resistant  
bacterial strains (Martinez, 2003). 
In some cases, antibiotics are not effective in the treatment of bacterial diseases, as is 
the case of mass mortality in Penaeus monodon larvae caused by Vibrio harveyi strains 
with multiple resistance to cotrimoxazole, chloramphenicol, erythromycin and 
streptomycin (Karunasagar, et al., 1994). Among these antibiotics, the first two were 
regularly used as prophylaxis (Cabello, 2006, Ishida, et al., 2010). 
Table 1.2 shows a panorama of the major classes of antibiotics used in the 
aquaculture industry and their importance in human medicine. Many antimicrobial agents 
used in human medicine are also used in aquaculture. In this way, the occurrence of 
resistance to these antibiotics in human pathogens severely limits the therapeutic options 
when treating infections in humans, and, therefore, the use of these antibiotics in animals 
must be controlled or prevented to avoid the spread of drug resistance. Among the 
antimicrobial agents commonly used in aquaculture, several are classified by the WHO 
(World Health Organization) as critically important for use in humans (Defoirdt, et al., 
2011). 
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Table 1.2 - Classes of antibiotics used in aquaculture, their importance for human medicine 
and examples of (multi)resistant pathogenic bacteria isolated from aquaculture (adapted 
from Defoirdt, et al., 2011). 
Drug class Importance 
for human 
medicinea 
Example Resistant bacteria Multipleb 
resistance 
Isolated from 
Aminoglycosides Critically 
importante 
Streptomycin Edwardsiella 
ictulari 
Yes Diseased striped catfish 
(Pangasianodon 
hypophthalmus), 
Vietnam 
Amphenicols Important Florfenicol Enterobacter spp. 
and 
Pseudomonas spp. 
Yes Freshwater salmon 
farms, Chile 
Beta-lactams Critically 
importante 
Amoxicillin Vibrio spp., 
Aeromonas spp. 
and Edwardsiella 
tarda 
Yes Different aquaculture 
settings, Australia 
Beta-lactams Critically 
importante 
Ampicillin Vibrio harveyi Yes Shrimp farms and 
coastal waters,Indonesia 
Fluoroquinolones Critically 
importante 
Enrofloxacin Tenacibaculum 
Maritimum 
Yes Diseased turbot 
(Scophthalmus 
maximus) and sole 
(Solea senegalensis), 
Spainand Portugal 
Macrolides Critically 
importante 
Erythromycin Salmonella spp. Yes Marketed fish, China 
Nitrofurans Critically 
importante 
Furazolidone Vibrio 
anguillarum 
Yes Diseased sea bass and 
seabream, Greece 
Nitrofurans Important Nitrofurantoin Vibrio harveyi Yes Diseased penaeid 
shrimp, Taiwan 
Quinolones Critically 
importante 
Oxolinic acid Aeromonas spp., 
Pseudomonas spp. 
and Vibrio spp. 
Yes Pond water, pond 
sediment and tiger 
shrimp (Penaeus 
monodon), Philippines 
Sulphonamides Important Sulphadiazine Aeromonas spp. Yes Diseased katla (Catla 
catla), mrigel 
(Cirrhinus mrigala) and 
punti (Puntius spp.), 
índia 
Tetracyclines Highly 
importante 
Tetracycline Aeromonas 
Hydrophila 
Yes Water from mullet and 
tilapia farms, Egypt 
Tetracyclines Highly 
importante 
Oxytetracycline Aeromonas 
Salmonicida 
Yes Atlantic salmon (Salmo 
salar) culture facilities, 
Canada 
a On the basis of World Health Organization Expert Consultations on ‘Critically Important Antimicrobials for 
Human Medicine’ (Heuer, et al., 2009). 
b Resistance to antibiotics belonging to different classes in at least one of the isolates. 
 
About half of all antibiotics in the world are for animal use, like in fish farming, 
where antibiotics are used as growth promoters (Lorch, 1999, Almeida, et al., 2009). In 
Asian countries a large variety of antibiotics is used. The equivalent of 500-600 tones per 
year are used prophylactically, some on a daily basis (Almeida, et al., 2009). 
In Thailand, in an interview with 76 shrimp producers, it was found that 56 used 
antibiotics (Holmström, et al., 2003). In the Phillipines, Tendencia and Pena it was 
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reported the use of a large variety of antibiotics, namely oxytetracycline, oxolinic acid, 
chloramphenicol, furozolidine, nitrofurans, erythromycin and sulfonamids (Tendencia & 
de la Peña, 2001). In South America, a wide range of antibiotics is also used in 
aquaculture, including oxytetracycline, florfenicol, trimethoprim-sulfamethoxazole, 
enrofloxacin and sarafloxacin (Roque, et al., 2001). In Europe, the use of antibiotics is also 
practiced in aquaculture, however, it is only allowed the use of a limited number of 
antibiotics, such as amoxacillin, ampicillin, chloramphenicol, erythromycin, florfenicol, 
flumequine, oxolinic acid, oxytetracycline, nitrofurazone, sulphadiazine-trimethoprim and 
tetracycline (Toranzo, et al., 1991, Bakopoulos, et al., 1995, Sano, 1998).  
Despite the need for a stricter control on the use of antibiotics in aquaculture, to 
minimize or reduce the spread of antibiotic and its resistance, few countries monitor the 
amount of antibiotics used in aquaculture and, in this way, it is impossible to obtain a 
complete view of all the agents that are used in the aquatic system (Smith, 2008, Heuer, et 
al., 2009). For example, recent studies made by Smith about the use of antibiotics reveal 
that there is a large variation between countries, ranging from 1 g per tonne of production 
in Norway to 700 g per tonne in Vietnam (Smith, 2008). 
The use of antibiotics in aquaculture requires implementation of stricter regulations 
as well as regulations on the presence of antibiotic residues in aquaculture products (FAO, 
2002). Although in some countries (like Japan and other countries in Europe and North 
America) there are already strict regulations on the use of antibiotics and only a few 
antibiotics are licensed for use in aquaculture, a large part of the world aquaculture 
production occurs in countries that have few or even no regulations (FAO, 2002, Smith, 
2008).  
When aquaculture products from countries that do not have adequate regulations are 
to be exported, they must follow the stricter regulations of the importing countries 
regarding the presence of antibiotic residues. In addition, all exporting countries have to 
fulfill the requirements of the Hazard Analysis and Critical Control Points (HACCP) for 
international trade (FAO, 2002).  
Although the administration of antibiotics has been approved by the authorities, 
representing a low-cost and relatively easy application, this strategy has limited success 
when compared with the economic losses caused by bacterial infections (Oliveira, et al., 
2012). 
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Antibiotic resistance became, in recent years, a public health problem that must be 
solved as soon as possible. The solution for this problem passes by a difficult resolution 
that requires behavioural changes at various levels: at hospitals, with regard to medical 
behaviour in relation to the administration of antibiotics, and changes at the farm level and 
control of the use of these substances in animal exploration (Mellon, et al., 2001). 
Therefore, to reduce the risk of development and spread of microbial resistance and 
to control fish diseases in aquaculture, it is necessary to develop alternative strategies more 
environmentally friendly and economically viable (Almeida, et al., 2009). 
 
1.2.3.1 The use of antibiotics in aquaculture and the associated risks for 
human medicine  
 
The use of antibiotics in aquaculture presents a risk to public health because of the 
potential development of antimicrobial resistance in fish pathogenic bacteria and in other 
aquatic bacteria. Antimicrobial resistance in fish pathogenic bacteria can act as reservoirs 
of resistance genes, from which genes can spread to human (Heuer, et al., 2009, Defoirdt, 
et al., 2011). For example, studies simulated in natural microenvironments indicate that the 
dissemination of resistance of R plasmids (plasmids harboring multiple antimicrobial-
resistance determinants) can occur from Aeromonas species to Escherichia coli (Kruse & 
Sørum, 1994, Heuer, et al., 2009). This form of spreading of antimicrobial resistance from 
aquatic environments to humans can be viewed as a form of indirect spread by horizontal 
gene transfer. Furthermore, some groups of aquatic bacteria (for example, some species of 
Vibrio) are considered as pathogens and other bacterial species may be opportunistic 
pathogens in humans. When a human infection is caused by bacteria of these groups, this 
form of antibiotic resistance dissemination is seen as direct transmission of antibiotic 
bacterial resistance from the aquatic environment (Heuer, et al., 2009).  
In addition to antibiotic resistant bacteria that represent a high risk to human health, 
the presence of antimicrobial residues in aquaculture products and the horizontal 
transference of genes also present a risk to humans and is often associated with allergies, 
toxicity, altered intestinal flora and selection of antimicrobial resistant bacteria (Paige, et 
al., 1997, Cabello, 2006). However, the risk associated with antimicrobial residues 
depends on the type and amount of the antimicrobial agent found or consumed and, 
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generally, lower exposure means lower risk. Despite the risk associated with the ingestion 
of antimicrobial residues in food, toxicological effects of antimicrobial residues in food 
pose less risk to human health than the risk associated with antimicrobial resistant bacteria 
in foods (Kruse & Sørum, 1994). Furthermore, antibiotic-resistant bacteria also enter the 
marine environment by human or animal sources and have the ability to disseminate their 
resistance genes, increasing the problems associated with antibiotic resistant bacteria in the 
environment, such as, for example, the fish farms (Baquero, et al., 2008).  
The determining factors of antibiotic resistance that have emerged and/or evolved in 
the aquaculture environment are often located on mobile genetic elements. Resistant genes 
have been detected in transferable plasmids and integrons in pathogenic bacteria, such as 
Aeromonas spp., Citrobacter spp., Edwardsiella spp., Photobacterium spp. and Vibrio spp. 
(Ishida, et al., 2010). 
It has been well documented that fish pathogens and other aquatic bacteria can 
develop resistance as a consequence of exposure to antimicrobial agents. For example, a 
strain of A. salmonicida that causes disease in fish from temperate and cold climates, 
acquired resistance to sulphonamide and to quinolones. Resistance to quinolones in strains 
of A. salmonicida was mainly mediated by mutation in the gyrase A gene (gyrA) (Heuer, et 
al., 2009). Resistance to norfloxacin, oxolinic acid, trimethoprim, and sulphamethoxasole 
was found in a local shrimp farming in Vietnam, and Bacillus and Vibrio species were 
predominant among bacteria that were resistant to these antimicrobials (Le, et al., 2005). 
Resistance to sulphonamides in bacteria from shrimp hatcheries in India was also reported 
(Otta & Karunasagar, 2001). The problem of antibiotic resistance is even more concerning 
because some bacteria that are responsible for infections in fish belong to the same genera 
of the bacteria that cause infections in humans, increasing the probability of dissemination 
of antimicrobial resistance from aquaculture pathogens to human beings. For example, it 
has been demonstrated that plasmids harbouring the resistance determinants are 
transferable from fish pathogens and aquatic bacteria, not only to other bacteria of the 
same gender, but also to E. coli (Kruse & Sørum, 1994, Akinbowale, et al., 2007). 
Plasmids carrying multiresistance determinants have shown to be transferable to E. coli 
from A. salmonicida, A. hydrophila, E. tarda, Citrobacter freundii, P. damselae subspecies 
piscicida, V. anguillarum, and V. salmonicida (Heuer, et al., 2009). Plasmids transporting 
resistance to six antimicrobial agents were transferable from Vibrio cholerae O1 to A. 
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salmonicida, A. hydrophila, Vibrio parahaemolyticus, V. cholerae, V. anguillarum, 
Shigella species, Salmonella species and E. coli (Kruse, et al., 1995). The genes that confer 
tetracycline resistance isolated in Japan in fish farm bacteria and human clinical bacteria 
showed high similarity, suggesting that they were derived from the same source (Furushita, 
et al., 2003). In laboratory assays, tetracycline resistance from marine strains of 
Photobacterium species, Vibrio species, Aeromonas species and Pseudomonas species was 
transferred to E. coli by conjugation. The transference of plasmids containing resistant 
genes from fish pathogenic bacteria and other aquatic bacteria shows that these bacteria 
may act as reservoirs of resistance genes that can be further spread. Furthermore, 
molecular characterization of some resistance determinants indicates that antimicrobial 
resistance genes can be exchanged between fish pathogenic bacteria and human bacteria 
(Heuer, et al., 2009).  
Besides the indirect spread of antimicrobial resistance by horizontal gene transfer, 
dissemination of genes from aquatic antibiotic resistant bacteria to humans bacterial 
pathogens may also occur in a direct way (Heuer, et al., 2009). Therefore, antimicrobial 
treatment of infections caused by these bacteria can result in failures in the treatment of 
infections in humans. The way of dissemination of antimicrobial resistance to humans can 
be by direct contact with water or aquatic organisms, through drinking water, or through 
handling or consumption of aquaculture products. Direct dissemination from aquatic 
environments to humans may involve human pathogens, such as V. cholerae, V. 
parahaemolyticus, Vibrio vulnificus, Shigella species, and Salmonella species, or 
opportunistic pathogens, such as A. hydrophila, Plesiomonas shigelloides, E. tarda, 
Streptococcus iniae, and E. coli. The occurrence of antibiotic resistance in Salmonella 
species in aquatic environments is probably attributed to contamination of human or 
animal origin, or from agricultural environments (Heinitz, et al., 2000). 
The transference of antibiotic resistance from aquaculture bacteria to humans has 
enormous consequences, namely the increasing of the number of infections in humans. 
This fact makes the treatment of microbial infections more difficult, because individuals 
that are in contact with an antimicrobial agent have a higher risk of infection with 
pathogens that are resistant to the same antimicrobial agent. Antibiotic resistance also 
increases the frequency of treatment failures, which may lead to an increased severity of 
the infection. The increase of treatment failures in humans, as a result of antibiotic 
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resistance, may result in a prolonged duration of the disease, resulting in a prolonged 
presence of the infection on the bloodstream, prolonged hospitalization, or increased 
mortality (Kruse & Sørum, 1994). For example, prolonged disease has been demonstrated 
in studies of fluoroquinolone resistant Campylobacter and for infections caused by 
quinolone-resistant Salmonella typhimurium an increased severity of the infection has been 
demonstrated (Smith, et al., 1999, Neimann, et al., 2003, Helms, et al., 2004). Thus, the 
increasing resistance to antibiotics, including multirresistant bacteria, has become in recent 
years one public health problem, which has to be solved quickly. Without a solution, the 
treatment of bacterial infections will be more and more difficult. To solve this problem, 
more effective and environmentally friendly alternatives for the prevention and control of 
bacterial diseases are required. 
 
1.3 Phage therapy: an alternative to antibiotics 
 
Phage therapy is gaining more attention as a promising alternative to antibiotics and 
other antibacterial chemicals, to control and prevent bacterial diseases and to prevent the 
spread of multiresistant bacteria in aquaculture (Nakai & Park, 2002). 
Phage therapy involves the use of bacteriophages, lytic viruses that specifically 
inactive pathogenic bacteria, posing an effective alternative to antibiotics (Matsuzaki, et 
al., 2005, Clark & March, 2006). 
 
1.3.1 Application of phage therapy in aquaculture 
 
The success of phage therapy in aquaculture involves a series of steps. Knowing the 
causative infectious agent it is subsequently possible to select the phage that may be able to 
efficiently infect the target bacteria, and thus, control the bacterial diseases in aquaculture. 
These steps include: (1) isolation of lytic bacteriophages from the fish environment, using 
a method of enrichment; (2) production of a phage stock; (3) genotypic and phenotypic 
characterization of the phage; (4) typing of bacteria and bacteriophage; (5) selection of a 
suitable lytic phage for therapeutic use; (6) evaluation of the therapeutic efficacy of the 
phage infections in laboratory and field trials, and (7) recognition of virulent genes or other 
toxic factors on the bacteriophage (Nakai, et al., 2010). 
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The phage stocks to be used in aquaculture need to be prepared with some care, 
because these stocks should have high degree of purity. By this way, it is necessary to 
remove the bacterial debris (such as lipopolysaccharides and endotoxins), eliminating 
additional problems, since the contaminated phage suspensions can be fatal for the treated 
organism (Carlton, 1999, Inal, 2003, Efrony, et al., 2007). For the success of phage therapy 
is fundamental to characterize and type the bacteriophages, due to the high degree of 
phenotypic and genotypic diversity within populations of both bacteria and phages 
(Stenholm, et al., 2008). The preparation of a lytic phage to control the high diversity of 
pathogenic bacterial strains is critical because phages are generally strain specific. In this 
way, the preparation of cocktails with different lytic phages is a necessity (Nakai, et al., 
2010). 
The efficiency of phage therapy should be evaluated not only in vitro (in laboratory 
experiments) but also in natural environments, because a phage may exhibit lytic in 
properties in experimental environments but not in vivo (Sandeep, 2006). Furthermore, 
field assays also aim to establish the dose and route of phage administration. Concerning 
the treatment of fish with phage, the available data about the doses of phages and effective 
routes of administration are limited. However, in contrast to chemicals and other 
substances, a precise determination of the initial dose of the phage given to each fish may 
not be essential in aquaculture because the phages are able to increase along with the 
bacteria (Nakai, et al., 2010). 
Phage administration may be by injection, addition to culture water or impregnated 
feed (Nakai & Park, 2002). Even considering that the diseased fish cannot get sick eating 
so well, phage by impregnated feed allows the treatment of a large number of fish 
specimens (Nakai et al, 2010). This technique can be advantageous for infections that 
occur orally, since the bowel is also a route for the pathogen into the organism, and normal 
intestinal flora might be unaffected, but the target bacteria will be. Although treatment with 
the phage can also be accomplished by injection, it can be laborious when a large number 
of animals needs treatment or when dealing with very small animals. However, this 
approach is used for a series of vaccines on the market (Nakai, et al., 2010). The addition 
of phages in the culture water is also possible because these tend to remain stable and 
effective as if in a liquid culture medium (Nakai, et al., 1999). This type of administration 
has the advantage of being continuous and facilitates the physiological contact between the 
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infected organism and the bacteriophage (Summers, 2001, Inal, 2003). For this reason, the 
administration of therapeutic phages in water (immersion) will be more effective to 
organisms in which the infection is initiated by bacterial colonization of the skin and gills 
(Nakai & Park, 2002). Additionally, in terms of comparison of results between the 
laboratory and the field, the immersion approach allows greater similarity between 
environmental and laboratory conditions because the phage-bacteria interaction occurs in 
suspension (Summers, 2001). Treatment of larvae, juveniles or hatcheries eggs by the 
bathing or immersion techniques has been efficient, for example, in the biocontrol of 
Vibrio harveyi in Penaeus monodon larvae (Vinod, et al., 2006, Karunasagar, et al., 2007). 
In aquaculture, the possibility of using multiple routes of phage administration is very 
advantageous since microbial infections may occur in various stages, from eggs to 
broodstock (Nakai, et al., 2010). 
Regarding the phages immune response , they are recognized by the immune system 
of animals as external entities, and hence an immune response can be developed (Pirisi, 
2000, Sulakvelidze & Morris, 2001). Phage neutralizing antibodies may decrease phages 
efficacy in vivo so, for this reason, a higher dose of phage may be required in order to 
compensate non-viable phages that are processed by interaction with neutralizing 
antibodies (Carlton, 1999, Pirisi, 2000, Sulakvelidze & Morris, 2001). In order to 
overcome immune responses, it is important to test whether phage neutralizing antibodies 
are produced and for how long they remain in circulation, which factors of the vertebrate 
host immune response are capable of inactivating the phage and if the phage inoculations 
given too early may be less effective (Barrow & Soothill, 1997, Yuksel, et al., 2001, Payne 
& Jansen, 2003). However, the production of phage neutralizing antibodies after 
administration of the phage in aquaculture is not documented in the literature (Nakai, et al., 
1999, Oliveira, et al., 2012). The immune response is not a problem for phage therapy in 
invertebrate hosts, and this approach has proven effective in these organisms (Efrony, et 
al., 2007).  
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1.4 Advantages of phage therapy over chemotherapy in fish farms 
 
Phage therapy has many advantages when compared to chemotherapy: (1) it is 
effective against multi-resistant pathogenic bacteria because the mechanisms by which it 
induces the lysis of the bacteria are completely different from that of antibiotics. Bacteria 
will certainly develop resistance to the phage but, since the phage has a greater rate of 
mutation and replication it can adapt to the development of resistant bacteria and so the 
development of resistance is limited (Matsuzaki, et al., 2003, Matsuzaki, et al., 2005). The 
fact that the phage co-evolves with its bacterial host makes the discovery of new phages 
relatively easy when compared to the development of new antibiotics. In addition, bacteria 
that become resistant to a phage are infected by new phage mutants (Matsuzaki, et al., 
2003). Another possibility to reduce the appearance of resistant strains during treatment 
with the phage preparation is to make a mixture of different phage strains (Biswas, et al., 
2002, Watanabe, et al., 2007). Moreover, phage resistant bacteria are still not necessarily 
pathogenic because selection for resistance could select against virulence (Levin & Bull, 
2004, Sandeep, 2006, Nakai, et al., 2010); (2) The phages are usually highly specific to a 
single bacterial species or strain and therefore cause much less damage to the intestinal 
flora of normal fish and other non-target bacterial species (Matsuzaki, et al., 2003); (3) The 
phages are self-replicating and self-limiting, unlike antibiotics and thus have a limited 
impact. They replicate exponentially along with bacteria and decrease when the number of 
bacteria decreases, without any environmental risk. The number of times that the phage 
must be applied varies with the application, however, a single dose may be sufficient, and 
the determination of the precise initial dose may not be essential since titers may increase 
with bacterial infection (Inal, 2003, Mathur, et al., 2003); (4) The approval and regulation 
of the treatment with phages can be substantially simple since naturally occurring phages 
are very abundant; (5) The phages are resistant to environmental conditions, whether the 
phages are found in the same environment as the bacterial host or not, the capacity of these 
phages to survive in the same environment as their host bacteria is high (Durán, et al., 
2002, Lucena, et al., 2004); (6) The development of phage therapy is more cost-effective 
than the development of a new antibiotic and is faster and more flexible (Carlton, 1999, 
Matsuzaki, et al., 2005). 
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1.4.1 Phage cocktails in the treatment of bacterial infections 
 
Despite the proven success of phage therapy with just one phage, being this form of 
therapy effective when the pathogenic bacterial strain is known and clearly defined, there 
are certain factors that can lead to the failure of phage therapy when one phage alone is 
used. These factors are the development of phage resistance to the pathogenic bacteria and 
the narrow host range of the phages, which makes the control of bacterial species criticized 
because they are often strain specific phages. However, the use of phage cocktails 
circumvents these problems (Gill & Hyman, 2010, Nakai, et al., 2010). 
In phage infection, the attachment of the phage to the bacterium is one essential step. 
For this step to occur, the phage can use bacterial capsules, different parts of 
lipopolysaccharide (LPS), flagella, fimbriae and many other surface proteins as receptors. 
Furthermore, the phage may also use enzymes to break down capsule like materials on the 
bacterial surface, in a drill-like manner, to reach the cell wall of the bacterium (Skurnik & 
Strauch, 2006). The resistance of bacterial strains to lytic phages is partly due to mutations 
or by loss of the phage receptor (Shivu, et al., 2007). 
Bacteria that are phage resistant are not necessarily as pathogenic as the wild type 
because selection for resistance can be accompanied by a decrease in virulence. Because 
bacterial mutations can occur in the phage receptor, they can also act as a virulent factor 
(Merril, et al., 2006). In addition, the bacterium may become phage-resistant also by 
lysogeny conversion, whereby the bacterium becomes immune to the phage and to its close 
relatives (Skurnik & Strauch, 2006). 
The success of phage cocktails in the particular case of bacterial resistance requires 
that the selected phages do not possess overlapping cross-resistance, that is, bacterial 
mutants that are resistant to one phage are still sensitive to the other, and vice versa. Thus, 
cocktails containing only phages with LPS receptors can theoretically be less successful 
than a phage cocktail containing phages using different receptors. It is also needed that 
bacteria can be infected by several phages (Gill & Hyman, 2010). A concern regarding the 
use of phage cocktails is related to the ability of the phages to interfere with each other by 
co-infection. LMP-102 made by Intralytix Incorporated (Baltimore, MD, USA) is a 
successful example of the use of a phage cocktail to limit the development of host 
resistance. This product consists of a mixture of six bacteriophages infecting several strains 
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of L. monocytogenes, a common contaminant of fresh meat and meat products (Abedon & 
Thomas-Abedon, 2010).  
In the treatment of certain human diseases, when the pathogenic bacterial strain is 
not known and prompt treatment is required, the use of phage cocktails simplify the hired 
treatments by the use of individual phages (Dowd, et al., 2008, Abedon & Thomas-
Abedon, 2010). The need for phage cocktails is evident in the treatment of certain wound 
infections, where it is increasingly understood that these infections are due to 
polymicrobial communities instead of bacterial monocultures (Dowd, et al., 2008). Thus 
cocktails may serve as a first line treatment, followed by specific correspondence between 
phages and bacteria, if required (Gill & Hyman, 2010).  
The narrow host range of phages is pointed out as a drawback commonly listed in 
phage therapy when compared with antibiotics, however, the use of cocktails circumvents 
this disadvantage (Gill & Hyman, 2010). The commercial product PhagoBioDerm contains 
a variety of phages which are capable of lysing E. coli, Pseudomonas aeruginosa, S. 
aureus, Proteus and Streptococcus (Markoishvili, et al., 2002, Kutter, et al., 2010).  
To evaluate the efficacy of bacteriophages in the treatment of burn wound infections, 
one phage cocktail (BFC-1) consisting of three phages, a Myovirus and a Podovirus 
against P. aeruginosa and a Myovirus against S. aureus was prepared. BFC-1 was applied 
by a single spray application in the burn wound. One part of the wound was not treated 
with the phages and was used as a control. The patients were monitored for three weeks 
after the treatment and it were not observed any type of clinical abnormalities that could be 
related to the application of phages and the infection was controlled (Merabishvili, et al., 
2009, Kutter, et al., 2010). 
In aquaculture, the studies show contradictory results with regard to the appearance 
of phage-resistant bacteria. Some studies indicate bacterial resistance to phage as a 
consequence of phage therapy in diseased fish or in apparently healthy fish, but others do 
not show this effect (Park & Nakai, 2003). The therapeutic effects against infection in ayu 
were examined. In this study, the in vivo efficacy of the PPpW-4 (Podoviridae), PPpW-3 
(Myoviridae) and a mixture of both phages (PPpW-3/W-4) was evaluated against 
Pseudomonas plecoglossicida infection. The results show that the phage cocktail (PPp-
W4/ PPp-W3) exhibited high inhibitory activity when compared with the phage alone. This 
inhibitory activity shows that no phage-resistant organisms nor phage neutralizing 
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antibodies were detected in diseased fish or in apparently healthy fish, showing that the 
treatment with bacteriophages can be a potential alternative for the control of diseases 
(Park & Nakai, 2003).  
In addition to the potential use of phage cocktails for the treatment of fish diseases, 
the mixture of lytic bacteriophages for the biocontrol of food-borne pathogens in food 
industry is gaining increasing acceptance. In a recent study, the ability of a cocktail of five 
phages infecting Vibrio for the treatment of Vibrio cholera O1 in a rabbit model was 
examined. The phage cocktail (108 plaque forming unit), in one group of rabbits, was 
administrated 6 and 12 h prior to the administration of V. cholerae O1, while in the other 
group the same procedure was applied 6 and 12 h post infection. The results show that oral 
administration of the phage cocktail after oral bacterial challenge significantly lowered the 
shedding of bacteria, and in contrast, the phage treatment prior to bacterial challenge had 
no such effect. These results indicate that oral administration of the phage subsequent to V. 
cholerae challenge could provide a possible mean for combatting V. cholerae infection. 
Furthermore, the results showed that the phage cocktail could not only reduce the V. 
cholerae counts more rapidly when compared to the individual phages but also to a greater 
extent, indicating the possible usefulness of the phage cocktails as a therapeutic agent for 
combatting V. cholerae infection (Jaiswal, et al., 2013). Other study made with a phage 
cocktail composed of three different lytic bacteriophages (UAB_Phi 20, UAB_Phi78, and 
UAB_Phi87) was used in four different food matrices (pig skin, chicken breasts, fresh eggs 
and packaged lettuce) experimentally contaminated with Salmonella enterica serovar 
Typhimurium and S. enterica serovar Enteritidis. When pig skin was sprayed with the 
bacteriophage cocktail and then incubated at 33 ºC for 6 h, a significant reduction of 
Salmonella was obtained (> 4 and 2 log/cm2 for S. typhimurium and S. enteritidis, 
respectively). A significant bacterial reduction in the concentration of S. typhimurium and 
S. enteritidis was also observed in chicken breasts dipped for 5 min in a solution containing 
the bacteriophage cocktail and then refrigerated at 4 °C for 7 days (2.2 and 0.9 log10 
CFU/g, respectively) as well as in lettuce treated for 60 min at room temperature (3.9 and 
2.2 log10 CFU/g, respectively). However, in fresh eggs sprayed with the bacteriophage 
cocktail and then incubated at 25 ºC for 2 h, only a minor reduction of bacterial 
concentration (0.9 log10 CFU/cm2 of S. enteritidis and S. typhimurium) was achieved. 
These results demonstrate the potential efficacy of this phage cocktail as a biocontrol agent 
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for Salmonella in several food matrices, under conditions similar to those used in their 
production (Spricigo, et al., 2013). 
 
1.5 Objectives of the work  
 
Although several bacteriophages related to major aquaculture diseases have already 
been identified and characterized (Merino, et al., 1990, Myhr, et al., 1991, Munro, et al., 
2003, Martinez-Urtaza, et al., 2004), the application of phage therapy against bacterial 
diseases in aquaculture is not used as a routine. The main purpose of this work was to 
improve the phage therapy protocols in order to their effective use in aquaculture. 
The specific objectives were: 
 
 To test the effect of phage cocktails in the treatment of bacterial infections in 
aquaculture, particularly in the treatment of vibriosis. 
 
 To evaluate the effect of lysozyme addition on the activity of the phages. 
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Chapter 2: Efficiency of phage cocktails in the inactivation 
of Vibrio in aquaculture 
[In press. Aquaculture.] 
 
Abstract 
 
Aquaculture is one of the fastest growing sectors in the world, having a very 
important role in the economy. However, the losses associated with bacterial infections, 
such as vibriosis lead to huge economic costs. The regular use of antibiotics in aquaculture 
has resulted in the development of resistant strains, which have contributed to the 
inefficacy of antibiotics. To reduce the risk of the development and spreading of microbial 
resistance and to control the fish diseases in aquaculture, alternative strategies must be 
developed. Phage therapy can be an eco-friendly alternative to prevent and control 
pathogenic bacteria in aquaculture. However, phage bacterial resistance is already well 
documented but the use of phage cocktails can overcome this drawback.  
The aim of this study was to evaluate the efficiency of cocktails of two and three 
phages of Vibrio parahaemolyticus (VP-1, VP-2 and VP-3) to control Vibrio in 
aquaculture. All phages were effective against V. parahaemolyticus, however, the VP-3 
phage was the most efficient one (additional reduction of more 2 log when compared with 
the other two phages). The use of cocktails with two and three phages was significantly 
more effective (reductions of 4 log after 2 h) than the use of VP-1 and VP-2 phages alone 
(reductions of 0.8 log after 2 h), however, the efficiency of VP-3 phage was similar for the 
phage alone and for the phage in the cocktails (reduction of 3.8 log and 4.2 log for VP-3 
phage alone and in cocktails, respectively, after 8 and 6 h). All phages remained viable for 
a long time (at least 5 - 7 months) in marine water. The VP-3 phage presented a larger 
burst size and a shorter latent period (42 and 40 min, respectively) than the other two 
phages (9 and 120 min and 15 and 90 min, respectively, for VP-1 and VP-2 phages). 
Overall, the use of phage cocktails of two or three phages increased the efficiency of phage 
therapy against Vibrio (more efficient and faster bacterial inactivation), delaying the 
development of resistance by the bacteria and the use of Vibrio phages with high burst 
sizes and short lytic cycles also increases the efficiency of phage therapy. 
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Keywords: Phage therapy, pathogenic bacteria, vibriosis, phage cocktails, aquaculture 
system.  
 
Introduction 
 
In commercial aquaculture, unfavorable conditions such as: overfeeding, high 
temperature, fast growth, infrequent water renewal rate and improper removal of wounded 
and dead animals from the farming area, create favorable conditions for the emergence of 
bacterial diseases (Almeida, et al., 2009). 
Bacterial infections, including multidrug-resistant strains, have been recognized as an 
important limitation to the development of the aquaculture production (FAO, 2009, 
Oliveira, et al., 2012). Vibriosis, caused by bacteria from the family Vibrionaceae, are 
currently responsible for most outbreaks in aquaculture. Vibriosis is caused by species of 
Vibrio (namely V. parahaemolyticus, V. anguillarum, V. vulnificus, V. alfinolyticus and V. 
salmonicida) (Toranzo, et al., 1991, Hanna, et al.; 1992, Benediktsdottir, et al., 1998, 
Noya, et al., 1995, Sung, et al., 1999, Almeida, et al., 2009, Silva-Aciares, et al., 2013). 
V. parahaemolyticus is an important human bacterial pathogen that is widely 
distributed in marine environments, frequently isolated from a variety of seafood including 
codfish, sardine, mackerel, flounder, clam, octopus, shrimp, crab, lobster, crawfish, scallop 
and oyster (Liston, 1990; Su & Liu, 2007). This bacterium of marine environments is 
frequently associated with the development of acute gastroenteritis in human by 
consumption of raw or undercooked contaminated seafood, particularly shellfish (Kaysner 
& DePaola Jr, 2000). The regular use of artificial food supplemented with antibiotics in 
intensive and semi-intensive aquaculture systems, to prevent the spread of diseases and 
their massive use to control infections, has resulted in the development of resistant strains, 
which have contributed to the inefficacy of antibiotic treatments (Martinez, 2003). To 
reduce the risk of the development and spreading of microbial resistance and to control the 
fish diseases in aquaculture, alternative strategies must be developed (Defoirdt, et al., 
2011). Phage therapy can be used as an alternative to prevent and control pathogenic 
bacteria in aquaculture. 
A major concern regarding the use of phages in the treatment of infectious diseases is 
the emergence of phage-resistant mutants (Smith & Huggins, 1983; Gil & Hyman, 2010). 
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Resistance may arise due to the alteration or loss of the bacterial cell surface receptors, 
blocking of the receptors by the bacterial extracellular matrix, inhibition of phage DNA 
penetration, production of modified restriction endonucleases that degrade the phage DNA, 
or due to the inhibition of the phage intracellular development (Labrie, et al., 2010). 
Mutations affecting phage receptors represent the most frequent cause of bacterial phage 
resistance (Heller, 1992; Labrie, et al., 2010). 
Although the development of phage-resistance, when only one phage is used, has 
already been reported (Levin & Bull, 2004, Tanji, et al., 2005, Merril, et al., 2006, 
Sandeep, 2006, Skurnik & Strauch, 2006, Scott, et al., 2007, Nakai, et al., 2010, Vieira, et 
al., 2012; Silva, et al., 2013), this limitation can be overcame by the combined use of more 
than one phage at the same time, that is, by the use of phage cocktails (Crothers-Stomps, et 
al., 2010, Chan, et al., 2013). Furthermore, previous reports suggested that virulent 
bacteria that are resistant to phage infection could be less fit or could lose their pathogenic 
properties (Anonymus, 1983; Capparelli, et al., 2010, Fillippov, et al., 2011). Bacterial cell 
surface components that act as receptors for phage adsorption can also act as virulent 
factors, which may undertake mutation when bacteria develop resistance to phages, 
rendering them not pathogenic. 
Phage cocktails not only potentially provide a means to circumvent resistance to the 
presence of a single phage but they also allow the treatment of multiple pathogens 
simultaneously (Cairns, et al., 2009, Merabishvili, et al., 2009, Kunisaki, 2010). Therefore, 
the high specificity of bacteriophages, that sometimes can be considered to be a 
disadvantage of phage therapy, namely when the photogenic bacteria are not known, may 
be circumvented by the use of phage cocktails, which broaden the spectrum of action 
(Sulakvelidze, et al., 2001, Chan, et al., 2013). 
The aim of the present study was to test the efficacy of phage cocktails of two and 
three V. parahaemolyticus phages (VP-1, VP-2 and VP-3 phages) to control V. 
parahaemolyticus in aquaculture systems. The phages were tested alone and combined as 
cocktails. As the selection of appropriate bacteriophages is a key factor in the success of 
phage mediated-control of aquaculture infections, the three phages were characterized in 
terms of survival in the marine environment, host range, latent period and burst size. 
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Materials and methods 
 
Bacterial strains and growth conditions 
 
The bacterial strains, V. parahaemolyticus, V. anguillarum, A. salmonicida, P. 
aeruginosa, P. fluorescens, P. putida, P. segetis and P. gingeri, used in this study were 
previously isolated in our laboratory (Pereira, et al., 2011, Louvado, et al., 2012). The 
other bacterial strains, P. damselae subsp. damselae (ATCC 33539), E. coli (ATCC 
13706), V. fischeri (ATCC 49387), A. hydrophilla (ATCC 7966), were purchased from 
ATCC collection. Fresh plate bacteria cultures were maintained in solid Tryptic Soy Agar 
medium (TSA; Merck, Darmstadt, Germany) at 4 °C. Before each assay, one isolated 
colony was aseptically transferred to 10 mL of Tryptic Soy Broth medium (TSB; Merck, 
Darmstadt, Germany) and was grown overnight at 25 °C. An aliquot of this culture (100 
µL) was aseptically transferred to 10 mL of fresh TSB medium and grown overnight at 25 
°C to reach an optical density (O.D. 600) of 0.8, corresponding to about 109 cells per mL. 
 
Phages isolation and purification 
 
Three phages (VP-1, VP-2 and VP-3) were isolated from marine water samples 
(salinity 18-21; pH 7.6-7.7) of a semi-intensive aquaculture (earthen pond aquaculture 
system Corte das Freiras located in the estuarine system Ria de Aveiro, latitude: 
40º37´51.44´´N, longitude 8º40´31.75´´W, on the north-westem coast of Portugal) using V. 
parahaemolyticus as host. Five hundred milliliters of water were filtered sequentially by 3 
µm and then by 0.45 µm pore-size polycarbonate membranes (Millipore, Bedford, 
Billerica, USA). Filtered water was added to 500 mL of TSB with double concentration 
and to 1 mL of bacterial culture. The mixture was incubated at 25 °C for 18 h at 80 rpm, 
and then filtered through a 0.45 µm membrane. The presence/absence of the bacteriophage 
was verified through the spot test (Vieira, et al. 2012). Thirty microliters of the resulting 
filtrate were inoculated into TSA growth medium previously inoculated with the bacterial 
culture. The plates were incubated at 37 ºC for 4 - 12 h and inspected for zones of clearing. 
Three successive single-plaque isolations were performed to obtain a pure phage stock. All 
lysates were centrifuged at 10.000 g during 10 min at 4 °C, to remove intact bacteria and 
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bacterial debris. The phage stocks were stored at 4 °C and were added of 1% chloroform 
(Scharlau, Spain). The phage suspension titer was determined by the double-layer agar 
method using TSA as culture medium (Adams, 1959). The plates were incubated at 37 ºC 
for 4 - 8 h and the number of plaques was counted. The results were expressed as plaque 
forming units per millilitre (PFU mL-¹).  
 
Host range determination and efficiency of phage infection 
 
To determine the phage host specificity, the double-layer agar method was used. 
Spot test was performed with twelve bacteria (V. parahaemolyticus, A. salmonicida, V. 
anguillarum, P. damselae subsp. damselae, E. coli (ATCC 13706), V. fischeri (ATCC 
49387), A. hydrophilla, P. aeruginosa, P. fluorescens, P. putida, P. segetis and P. gingeri) 
to assess the bacterial susceptibility to the bacteriophage (Vieira, et al. 2012). The plates 
were incubated at 37 ºC for 4 - 12 h. The efficiency of plating was determined for the 
bacteria with positive spot tests (occurrence of a lysis zone) by the double-layer agar 
method using TSA as culture medium. Efficiency of plating for each host was calculated 
by comparison with an efficiency of 100% for the V. parahaemolyticus bacterium. For 
each phage, three independent experiments were done and the results were presented as the 
average of the three assays. 
 
Phage survival determination 
 
The survival of V. parahaemolyticus phages was tested in marine water of the 
aquaculture system Corte das Freiras, in three different dates, between May and July 2013. 
In each date, 50 mL of water were filtered through 0.45 μm and then by 0.22 μm pore-size 
membranes (Poretics, USA) which was followed by the addition of phage suspensions of 
about 107 PFU mL−1. The samples were then incubated at 25 °C without shaking, in the 
dark. Phage titer was determined at time zero and at intervals of 12 h until the first day, 24 
h until the fifth day, 48 h until the ninth day, 72 h until the twelfth day, 120 h until the 
forty-fifth day and 240 h until the end of the experiment (225 days), by the double-layer 
agar method. For each phage, three independent experiments were done.  
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One step growth assays 
 
Mid-exponential host bacterial cultures of V. parahaemolyticus were adjusted to a 1 
O.D. at 600 nm (corresponding to a cell density of 109 CFU mL-1). Ten microliters of the 
phage suspension were added to 10 mL of the bacterial culture in order to have a 
multiplicity of infection (MOI) of 0.001. The phage was allowed to adsorb for 5 min at 25 
ºC, without shaking. The mixture was centrifuged at 13.000 rpm for 5 min, the pellet was 
re-suspended in 10 mL of TSB at 37 ºC and was then serially diluted to 10
-4
. Samples (1 
mL) were taken at 10 - 20 min intervals and subjected to phage titration by the double-
layer agar method. Three independent assays were done.  
 
Phage therapy assays  
 
Phage therapy was performed using one phage alone (VP-1, VP-2 or VP-3) and with 
phage cocktails (two or all the three phages mixed together, each phage at the same 
concentration) using the bacterium V. parahaemolyticus as host, at a MOI of 100. The 
assays with two phages were performed with the following phage combinations: VP-1/ 
VP-2, VP-1/VP-3 and VP-2/VP-3 phages. After that, phage therapy was performed with 
the combination of the three phages (VP-1, VP-2 and VP-3). In order to obtain a MOI of 
100, 20 µL of the overnight V. parahaemolyticus culture (105 CFU mL-1) and 300 µL of 
the phage suspension (107 PFU mL-1), were inoculated into sterilized glass erlenmeyers 
with 30 mL of TSB medium and incubated at 25 ºC without agitation in the dark (test 
samples). 
When the assays were performed with the cocktail of two and three phages, the same 
concentration of each phage was added (100 µL of each phage at 107 PFU mL-1). For each 
assay, three control samples were included: the bacterial control (BC), the phage control 
and the phage cocktails controls (PC). The bacterial control was not inoculated with the 
phages and the phage controls were inoculated with the phage(s) but without the bacteria. 
All controls were incubated exactly in the same conditions as the test samples. Aliquots of 
test samples and of the bacterial and phage controls were collected after 0, 2, 4, 6, 8, 10, 
12, 18 and 24 h of incubation. For all phage therapy assays, the phage titer was determined, 
in duplicate, by the double agar layer method, after an incubation period of 4 - 12 h at 25 
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ºC. The bacteria concentration was determined, in duplicate, in TSA medium after an 
incubation period of 24 h at 25 ºC. Three independent experiments were performed for 
each condition. 
 
Statistical analysis 
 
Statistical analysis was performed using SPSS (SPSS 20.0 for Windows, SPSS Inc., 
USA). Normal distributions were checked by Shapiro-Wilk test and homogeneity of 
variances by Levene test. The existence of significant differences among the different 
phage therapy conditions was assessed by one-way analysis of variance (ANOVA) model 
with the Tukey post-hoc test. For each situation, the significance of the differences was 
done by comparing the results obtained in the test samples after correction with the results 
obtained for the correspondent control samples (difference between in the control and the 
test sample) for the different times of each of the three independent assays. A value of p < 
0.05 was considered to be statistically significant.  
 
Results 
 
Phages host range determination 
 
The VP-1 phage infected V. anguillarum and A. salmonicida, presenting an 
efficiency of 83.27 and 64.75%, respectively (Table 2.1). The VP-2 phage infected V. 
anguillarum and A. salmonicida with an efficiency of 93.39 and 92.03%, respectively 
(Table 2.1). The VP-3 phage also infected V. anguillarum and A. salmonicida, presenting 
an efficiency of 51.21 and 73.78%, respectively (Table 2.1). None of the three phages was 
effective against A. hydrophilla, P. damselae subsp. damselae, V. fischeri, E. coli, P. 
aeruginosa, P. fluorescens, P. putida, P. gingeri and P. segetis. 
  
 50 
 
Table 2.1- Efficiency of plating (%) to different bacteria. 
Fish bacteria 
Efficiency of phage plating (%) 
VP-1 VP-2 VP-3 
V. parahemolyticus 
V. anguillarum 
100 
83.27 
100 
93.39 
100 
51.21 
A. salmonicida 64.75 92.03 73.78 
A. hydrophilla 
V. fischeri 
0 
0 
0 
0 
0 
0 
P. damselae subsp. Damselae 0 0 0 
E. coli 
P. aeruginosa 
P. fluorescens 
P. putida 
P. segetis 
P. gingeri 
   0 
0 
0 
0 
0 
0 
   0 
0 
0 
0 
0 
0 
   0 
0 
0 
0 
0 
0 
 
Phage therapy assays  
 
Phage therapy using single-phage suspensions 
 
The maximum of bacterium inactivation with the VP-1 phage was 2.9 log achieved 
after 6 h of phage therapy (ANOVA, p < 0.05). After 12 h of phage therapy, the rate of 
inactivation (bacterial inactivation relatively to the bacterial control at each time) was still 
considerably high (2.1 log) (ANOVA, p < 0.05) (Figure 2.1A). No decrease of the phage 
survival was observed during the 24 h of the experiments, for the VP-1 phage alone and for 
the phage in the presence of its host V. parahaemolyticus. While the phage control 
remained almost constant during all experiment (ANOVA, p > 0.05), when the phage was 
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incubated in the presence of its host, a significant increase of 0.7 log was observed after the 
24 h (ANOVA, p < 0.05) (Figure2.1B). 
With the VP-2 phage, the maximum of bacterium inactivation was 3.6 log, achieved 
after 8 h of phage therapy (ANOVA, p < 0.05). However, after 6 h of incubation, the rate 
of inactivation was already 3.23 log (ANOVA, p < 0.05). After 12 h of treatment, the rate 
of inactivation was still considerably high (2.8 log) (ANOVA, p < 0.05) (Figure 2.1A). The 
phage control remained almost constant during all time (ANOVA, p > 0.05), but when the 
phage was incubated in the presence of its host, a significant increase of 0.7 log (ANOVA, 
p < 0.05) was observed after 24 h of phage therapy (Figure 2.1B). 
The maximum of bacterium inactivation by the VP-3 phage was 3.8 log, achieved 
after 8 h of phage therapy (ANOVA, p < 0.05). However, soon after 2 h of phage therapy, 
the rate of inactivation was already 2.6 log (ANOVA, p < 0.05). After 12 h of incubation, 
the rate of bacterium inactivation was still considerably high (2.1 log) (ANOVA, p < 0.05) 
(Figure 2.1A). The phage control remained almost constant during all experiment 
(ANOVA, p > 0.05) but the concentration of the phage incubated in the presence of its 
host, significantly increased (increase of 0.30 log) after the 24 h (ANOVA, p < 0.05) of 
phage therapy (Figure 2.1B). 
The rate of bacterial inactivation with the VP-3 phage (maximum reduction of 3.8 
log after 8 h) was, in general, significantly higher (ANOVA, p < 0.05) than those obtained 
with the VP-1 and VP-2 phages. The bacterial inactivation of VP-3 also started sooner, 
after 2 h, and the rate of inactivation (2.6 log) was significantly higher (ANOVA, p < 0.05) 
than those of VP-1 and VP-2 phages (0.6 and 0.8 log, respectively) (Figure 2.1A). 
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Figure 2.1 - Inactivation of V. parahaemolyticus by the three phages (VP-1, VP-2 and VP-3) at a MOI of 100 during the 
24 h of the experiments. A. Bacterial concentration: BC – Bacteria control; BP – Bacteria plus phage. B. Phage 
concentration: PC – Phage control; BP – Bacteria plus phage. Values represent the mean of three experiments; error bars 
represent the standard deviation. 
 
Phage therapy using phage cocktails 
 
When the phage therapy was performed with the VP-1/VP-2 phage cocktail, the 
maximum of bacterial inactivation was 4.0 log, achieved after 2 h of incubation, being 
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statistically different from the values obtained in the phage therapy with the phages alone 
(VP-1 or VP-2 phage) (ANOVA, p < 0.05) (Figure 2.2A). 
With the phage cocktail VP-1/VP-3, the maximum of bacterium inactivation was 3.8 
log. After 2 h of incubation, bacterial inactivation was significantly different (3.4 log) from 
the value obtained in the assays of phage therapy with the VP-1 phage alone (0.6 log) 
(ANOVA, p < 0.05). However, when comparing the results of the assays of phage therapy 
with the VP-3 phage alone with the phage cocktail (VP-1/VP-3), no significant differences 
were observed after the same period of time (ANOVA, p > 0.05). After 4 h of incubation, 
the rate of bacterial inactivation was 3.7 log, being statistically different from the results of 
the phage therapy with the VP-1 phage alone (ANOVA, p < 0.05) unlike with what was 
observed for the VP-3 phage (Figure 2.2A). 
In the phage therapy assays with the phage cocktail VP-2/VP-3, the maximum rate of 
bacterium inactivation was 3.6 log after 2 h of incubation, which was significantly 
different from those obtained in the assays of phage therapy with the VP-2 and VP-3 
phages, both alone (ANOVA, p < 0.05). After 4 h of incubation, bacterial inactivation was 
3.3 log in the experiment with the phage cocktail VP-2/VP-3, and was statistically 
significant when compared with the therapy with the VP-2 phage alone (ANOVA, p < 
0.05). However, when compared with the therapy with the VP-3 phage alone, no 
significant differences were observed for the same period of time (ANOVA, p > 0.05) 
(Figure 2.2A). 
When the assays of phage therapy were performed with the three phages altogether, 
VP-1/VP-2/VP-3 cocktail, the maximum rate of bacterial inactivation was 4.2 log, 
achieved after 6 h of incubation, being statistically different (ANOVA, p < 0.05) from the 
experiments with the VP-1 phage alone (Figure 2.2A). However, for the same period of 
time, no significant differences were observed in the assays of therapy with the VP-2 and 
VP-3 phages alone (ANOVA, p > 0.05). Nevertheless, after 2 h of incubation, the rate of 
phage inactivation was 3.6 log, being statistically different from the values obtained for the 
phage therapy with the three phages alone (ANOVA, p < 0.05). After 4 h of phage therapy, 
the rate of inactivation with the phage cocktail VP-1/VP-2/VP-3 was 3.5 log, which was 
not statistically different from the therapy with the VP-3 phage alone (ANOVA, p > 0.05), 
but was significantly different from the therapy with the other two phages alone (VP-1 and 
VP-2) (ANOVA, p < 0.05). After 8 h of incubation, the bacterial inactivation was 3.7 log 
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in the three phage cocktail experiment, which was statistically different from the values 
obtained in the phage therapy with the VP-1 phage alone (ANOVA, p < 0.05) (Figure 
2.2A). Comparing the values of the BC during the 24 h experiment, there were not 
observed any significant differences among the controls (ANOVA, p > 0.05) (Figure 
2.2A).  
 
 
 
Figure 2.2 - Inactivation of V. parahaemolyticus by phage cocktails at a MOI 100 during the 24 h of the experiment. A. 
bacterial concentration: BC – Bacteria control; BP – Bacteria plus phage. B. Phage concentration: PC – Phage control; 
BP – Bacteria plus phage. VP-1 – phage VP-1; VP-2 – phage VP-2, VP-3 – phage VP-3. Values represent the mean of 
three experiments; error bars represent the standard deviation. 
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No decrease of the phage survival (ANOVA, p > 0.05) was observed during the 24 h 
of the experiments for the VP-1, VP-2 and VP-3 phage controls and for the phage cocktails 
controls (PC) (Figure 2.2B). The suspensions with the phages alone and with the phage 
cocktails, when incubated in the presence of the host, presented a significant increase 
(ANOVA, p < 0.05), especially for the phage cocktails (Figure 2.2B). A significant 
increase of 1.8 log, 2.3 log, 1.5 log and 1.9 log was observed after 24 h of incubation 
(ANOVA, p < 0.05) for the phage cocktails VP-1/VP-2, VP-1/VP-3, VP-2/VP-3 and VP-
1/VP-2/VP-3, respectively (Figure 2.2B). 
 
Phage survival in marine water 
 
The phage survival experiments in the aquaculture water collected at different 
sampling times revealed that all the three phages maintained their viability during long 
periods in marine water (5 - 7 months). The VP-1 phage remained viable during at least 5 
months. VP-1 phage abundance decreased by one order of magnitude during the first day 
and reached a plateau thereafter, until the 25 th day. Afterwards, the phage titer slightly 
decreased until the 55 th day and more rapidly up to the 175  th day (Figure 2.3). The VP-2 
phage remained viable during at least 7 months. The VP-2 abundance decreased by one 
order of magnitude in the first day and reached a plateau in the further 12 days. 
Afterwards, the phage titer slightly decreased until the 35 th day and more rapidly up to the 
225 th day (Figure 2.3). The VP-3 phage survival assay showed that this phage remained 
viable during at least 7 months. The phage abundance decreased by one order of magnitude 
in the first 20 days, reaching a plateau during the further 55 days. Afterwards, the phage 
titer slightly decreased until the 85 th day and more rapidly up to the 225  th day (Figure2.3). 
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Figure 2.3 - VP-1, VP-2 and VP-3 phage survival in aquaculture marine water. Values represent the mean of three 
experiments; error bars represent the standard deviation. 
 
Burst size and explosion time 
 
The results of the phage one-step growth experiments revealed that the explosion 
time of the VP-1 phage occurred at 120 min of incubation. Each infected bacteria 
produced, in average, 9 phages. When one-step growth experiments were done using VP-2 
phage, the explosion time occurred at 90 min and each infected bacteria produced an 
average of 15 phages. For the VP-3 phage, the explosion time was at 40 min and each 
infected bacteria produced 42 phages (Figure 2.4). 
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Figure 2.4 - VP-1, VP-2 and VP-3 phage one-step growth experiments in the presence of V. parahaemolyticus as host. 
Values represent the mean of three experiments; error bars represent the standard deviation. 
 
Discussion 
 
Phage therapy is considered to be a viable alternative to antibiotics for the 
inactivation of bacterial pathogens in aquaculture systems (Nakai, et al., 1999; Park, et al., 
2000, Nakai & Park, 2002, Park & Nakai, 2003, Vinod, et al., 2006, Karunasagar, et al., 
2007; Shivu, et al., 2007, Verner-Jeffreys, et al., 2007; Higuera, et al., 2013; Martínez-
Díaz & Hipólito-Morales, 2013). The major challenge of phage therapy is the regular 
emergence of phage resistant bacteria (Levin & Bull, 2004, Tanji, et al., 2005, Merril, et 
al., 2006, Sandeep, 2006, Skurnik & Strauch, 2006, Scott, et al., 2007, Nakai, et al., 2010, 
Vieira, et al., 2012, Silva, 2013) which imply the ongoing isolation of new phages or 
variants of phages. However, it has been reported by some authors that the development of 
phage-resistance can be circumvented by the use of phage cocktails (Crothers-, et al., 
2010; Filippov, et al., 2011, Chan, et al., 2013). Although there are few studies about the 
use of phages to control vibriosis in aquaculture (Vinod, et al., 2006; Higuiera, et al., 
2013), there is not yet any report about the use of phage cocktails to control vibriosis in 
aquaculture.  
Here, we present evidence that phage cocktails can be successfully used to treat 
Vibrio infections. All the phage cocktails tested (two or all the three phages mixed 
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together) to inactivate V. parahaemolyticus were more efficient to control the bacterial 
growth than the single-phage suspensions. Moreover, with the exception of the VP-3 phage 
suspension, the bacterial inactivation with the phage cocktails occurred sooner than those 
obtained using the phages alone. For all of the phage cocktails, a high rate of inactivation 
was observed after 2 h of treatment, which was only observed for VP-3 phage alone. For 
the other two phages, the maximum of inactivation was observed only after 6 - 8 h of 
treatment. However, with the cocktail of these two phages, VP-1/VP-2, the maximum of 
inactivation was also observed after 2 h of phage addition. The increase in the efficiency of 
phage therapy (a faster and higher rate of bacterial inactivation) by this phage cocktail, 
relatively to the use of single-phage suspensions of these two phages, can be due to a delay 
in the development of phage bacterial resistance. These two phages probably used different 
bacterial receptors to be adsorb to V. parahaemolyticus and, consequently, the time 
necessary to develop resistance to both phages is higher. However, when the most efficient 
phage (VP-3), was used in the cocktails, the efficiency of the phage cocktails did not 
increase significantly comparatively to the use of VP-3 phage alone. This can be explained 
by the fact that the VP-3 phage may use the same bacterial receptor of the VP-1 and/or VP-
2 phages. In fact, when the phage cocktail VP1/VP3 was used, after 2 h of treatment the 
efficiency of inactivation was not significantly different from that observed for the VP-3 
phage alone, but when the phage cocktails VP-2/VP-3 was used the efficiency of 
inactivation, after the same period of time, was significantly different from that observed 
for VP-3 phage alone. This suggests the VP-1 and VP-3 phages may use the same receptor 
to infect V. parahaemolyticus. Consequently, in order to delay the development of 
resistance against the phages, the selection of the phages to be included in a specific 
cocktail should have into account the type of the bacterial receptor that each phage uses to 
infect its host. In fact, Filippov, et al., (2011) showed that the use of phage cocktails can 
overcome the problem of bacterial resistance, but only if the phages exploit different 
receptors. Further studies, including the identification of the bacterial receptors used by the 
tested phages to infect the bacterium V. parahaemolyticus, are necessary to confirm this 
hypothesis. 
The use of several phages in the form of cocktails increases their potential to be used 
presumptively, that is, prior to identification of the pathogens, and the more phages that are 
included, greater will be the potential of the cocktail against the pathogenic bacteria. 
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However, having too many phages in a cocktail could result in a greater impact on non-
target bacteria, although in most cases this impact is still less than that expected from 
typical commercial antibiotics (Chan, et al., 2013). Too many phages per formulation can 
also result in a higher development and manufacturing costs. Moreover, in cocktails 
containing multiple phages of the same genus with different host ranges, there is a 
substantial possibility for recombination among such phages to generate new host 
specificities (Essoh, et al., 2013) According to Chan, et al (2013), less complex cocktails, 
for example, two to ten distinct phages, potentially is the best option.  
Phage therapy with phage cocktails, as well as with single-phage suspensions, 
however, did not prevent the bacterial re-growth after treatment. This indicates that 
although the use of cocktails can retard the development of bacterial resistance, the host 
can eventually develop resistance against all phages. However, the delay in the 
development of resistance by the bacteria is an important achievement. Moreover, previous 
reports suggest that virulent bacteria that are resistant to phage infection could be less fit or 
could lose their pathogenic properties (Anonymus, 1983, Wagner & Waldor, 2002, 
Capparelli, et al., 2010, Fillippov, et al., 2011). Bacterial cell surface components that act 
as receptors for phage adsorption, can also act as virulent factors that can undertake 
mutation when the bacteria develop resistance to the phages, being no more pathogenic. 
We also showed that the selection of appropriate bacteriophages is a key factor in the 
success of phage-mediated control of Vibrio. Among the criteria that should be required for 
the selection of the phages to be used in phage therapy are: 1) host range; 2) latent period; 
3) burst size, and, 4) survival in the environment. The three dsDNA phages tested in this 
study (isolated on V. parahaemolitycus) 1) infected the same hosts (V. parahaemolitycus, 
V. anguillarum and A. salmonicida), 2) presented high periods of survival in marine 
aquaculture water, however, 3) the VP-3 phage showed higher efficiency for the 
inactivation of V. parahaemolitycus than the VP-1 and VP-2 phages and 4) has a shorter 
latent period and a higher burst size than the other two phages. These results indicate that 
the use of phages with high burst sizes and short lytic cycles clearly improve the efficiency 
of phage therapy. The VP-3 phage, that presents the highest burst size (more than 3 times 
of those of VP-1 and VP-2 phages) and the shortest lytic cycle (less than an half of those of 
VP-1 and VP-2 phages), was more efficient to inactivate V. parahaemolyticus than VP-1 
and VP-2 phages (more 2 log of inactivation, with the maximum of inactivation occurring 
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4 - 6 hours before than those of VP-1 and VP-2 phages). These results agree with previous 
reports which indicate that an upsurge in burst size may contribute to larger plaques and 
higher burst size (Abedon & Culler, 2007). 
The three phages infect a similar host range, which can be explained by the fact that 
all of the phages were isolated using the same strain of V. parahaemolyticus as a host. The 
VP-1, VP-2 and VP-3 phages can inactivate pathogenic bacteria from different families (V. 
parahaemolitycus, V. anguillarum and A. salmonicida) with high efficiency. This suggests 
that these phages can be used not only to treat vibriosis but also furunculose. These results 
are in agreement with previous studies that showed that some phages may infect more than 
one related species of bacteria or even genus (Carlton, 1999; Fuhrman, 1999, Thingstad, 
2000). 
 
Conclusion 
 
The use of phage cocktails with two or three phages increases the efficiency of phage 
therapy against Vibrio, delaying the development of resistance by the bacterial host, and 
the use of Vibrio phages with high burst sizes and short lytic cycles also increases the 
efficiency of bacterial inactivation. 
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Chapter 3: Effect of lysozyme addition on the activity of 
phages against Vibrio parahaemolyticus 
[Submitted to Microbial Biotechnology] 
 
Abstract 
 
Bacterial diseases are one of the major constraints for the development of the 
aquaculture sector, resulting in huge economic losses. Due to of the alarming level of 
antibiotic resistance in common pathogenic bacteria and the difficulties with treatment, 
alternative new methods to control fish pathogenic bacteria are needed. Phage therapy 
gained increased attention as an alternative to antibiotics in order to control bacterial 
diseases and prevent the spreading of multiresistant bacteria in aquaculture. However, the 
effect of lytic enzymes applied during phage therapy has not yet been evaluated. In this 
study, for the first time, the addition of lysozyme on the activity of three phages of Vibrio 
parahaemolyticus (VP-1, VP-2 and VP-3) to control Vibrio infection in aquaculture 
systems was evaluated. Therefore, different concentrations of lysozyme were tested for the 
three phages in order to determine the most effective concentrations. The results obtained 
indicate that the combination of lysozyme and phage showed better activity in comparison 
to the activity of the phage alone. VP-1 and VP-2 phages in the presence of high lysozyme 
concentration were more effective in reducing bacterial concentration (reductions of 4.0 
log) than the VP-3 phage with lysozyme. However, VP-3 phage (which was the most 
efficient against Vibrio) in the presence of low lysozyme concentration was also effective 
(reductions of 3.2 log). The addition of external lysozyme can improve the profile of less 
effective phages during phage therapy but for more effective phages the addition of 
lysozyme does not produce a so clear effect. Overall, the application of the phage along 
with lysozyme can be a very useful strategy to eliminate or reduce fish pathogenic bacteria 
in aquaculture, namely when less effective phages are available. 
 
Keywords: Phage therapy, aquaculture, fish pathogenic bacteria, lysozyme 
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Introduction 
 
Seafood production in aquaculture provides a good source of high-quality protein 
and is an important cash income in many parts of the world. It is estimated that the world 
population obtains at least 20% of its animal protein intake from finfish and shellfish 
(FAO, 2012). However, microbial disease outbreaks are one of the major constraints for 
the development of the aquaculture sector resulting in huge economic losses (Hektoen, et 
al., 1995, Oliveira, et al., 2012). Microbial diseases are often due to unfavorable conditions 
like high temperatures, high densities, rapid growth and overfeeding in fish cultivation, 
infrequent water renewal rate and improper removal of wounded and dead fishes from the 
farming area (Wahli, et al., 2002, Almeida, et al., 2009). The typical fish farming diseases 
are caused by main biological agents like bacteria, viruses, parasites and oomycetes, 
however, bacterial diseases are a major problem in the expanding aquaculture industry 
(Alderman, 1996, Wahli, et al., 2002, Almeida, et al., 2009). 
Vibrio species cause vibriosis, a common disease in marine and estuarine fish 
worldwide, both in natural and commercial production systems, and also occurs in 
freshwater fishes (Toranzo, et al., 1991, Noya, et al., 1995, Almeida, et al., 2009, 
Isnansetyo, et al., 2009). Vibriosis is caused by bacteria of the genera Vibrio (V. 
anguillarum, V. vulnificus, Vibrio parahaemolyticus, V. alfinolyticus) (Toranzo, et al., 
1991, Hanna, et al., 1992, Noya, et al., 1995, Sung, et al., 1999, Almeida, et al., 2009). 
V. parahaemolyticus is a halophilic Gram-negative bacterium known to be an 
important human pathogenic bacterium (Su & Liu, 2007). This bacterium is widely 
distributed in the marine environments, frequently isolated from a variety of seafood 
including codfish, sardine, mackerel, flounder, clam, octopus, shrimp, crab, lobster, 
crawfish, scallop and oyster (Liston, 1990, Wong, et al., 2000, Daniels, 2000b, Su & Liu, 
2007). It is frequently associated with the development of acute gastroenteritis in human by 
consumption of raw or undercooked contaminated seafood, particularly shellfish (Kaysner 
& DePaola Jr, 2000).  
Although the administration of antibiotics in aquaculture has been widely used to 
control vibriosis, this strategy has a serious negative impact on the environment, increasing 
the problem of bacterial resistance, and leading to their accumulation in the flesh of 
cultured marine animals (Nonaka, et al., 2000, Alcaide, et al., 2005, Le, et al., 2005, 
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Sarter, et al., 2007). To reduce the risk of development and dissemination of microbial 
resistance and to control fish diseases in aquaculture, alternative strategies must be 
developed in order to improve food quality and safety. Phage therapy in aquaculture seems 
to be a very promising technique and gained increased attention as a possible alternative to 
antibiotics, in order to control microbial diseases and to prevent the spreading of 
multiresistant bacteria in aquaculture (Nakai & Park, 2002, Inal, 2003, Nakai, 2003, 
Skurnik & Strauch, 2006, Karunasagar, et al., 2007, Shivu, et al., 2007, Verner–Jeffreys, et 
al., 2007, Higuera, et al., 2013, Martínez-Díaz & Hipólito-Morales, 2013, Silva-Aciares, et 
al., 2013, Silva et al., 2013).  
Although the use of phage lytic enzymes (endolysins) has now been described to 
reduce the number of an extensive range of bacteria (Tsugita, et al., 1968, Borysowski, et 
al., 2006, Drulis-Kawa, et al., 2012, Díez-Martínez, et al., 2013), there is no report 
assessing the effect of phage therapy in the presence of lytic enzymes. Lytic enzymes are 
encoded by phage genome to facilitate the infection or to destroy the bacterial cell wall. 
The lytic enzymes used to infect the bacterial cell are components of the virion tail, which 
are able to locally digest the cell wall from the outside to facilitate the injection of the 
phage genome into the host cell. These kind of lytic enzymes are widespread in virions, 
infecting Gram-positive or Gram-negative bacteria (Hogg, 2005). A classic example is the 
T4 phage lytic enzyme, which is inserted into a baseplate protein of the tail tube, at the tip 
of the tube (Hermoso, et al., 2007). The lytic endolysins used to weak the cell wall are 
synthesized in bacterial cells during phage multiplication, by the end of the lytic cycle, 
they act on the cell wall from inside the cell, facilitating the release of the virions (Fastrez, 
1996, Umasuthan, et al., 2013). 
Lysins can be classified according to their catalytic activity as lysozymes or 
muramidases, glucosaminidases, N-acetylmuramoyl-L-alanine-amidases (NAM-amidases), 
endopeptidases and lytic transglycosylases. Glucosaminidases, lysozymes and lytic 
transglycosylases act on the sugar moiety (glycosidases), whereas endopeptidases cleave 
the peptide cross-bridge and NAM-amidases hydrolyze the amide bond connecting the 
sugar and peptide constituents of peptidoglycan (Hermoso, et al., 2007). 
These lytic enzymes, namely the lysozymes, are also produced by other eukaryotes 
and prokaryotes, being involved in non - specific defence mechanism (Burge, et al., 2007). 
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As the isolation and purification of these enzymes is easier than those of phages, they can 
be externally added in order to facilitate the phage penetration during phage therapy. 
The aim of the present study was to evaluate the effect of lysozyme from chicken egg 
white on the activity of three phages of V. parahaemolyticus (VP-1, VP-2 and VP-3 ) in the 
control of Vibrio. 
 
Materials and methods 
 
Bacterial strains and growth conditions 
 
The bacterial strains, V. parahaemolyticus, V. anguillarum, A. salmonicida, P. 
aeruginosa, P. fluorescens, P. putida, P. segetis and P. gingeri, used in this study were 
previously isolated in our laboratory (Pereira, et al., 2011, Louvado, et al., 2012). The 
other bacterial strains, P. damselae subsp. damselae (ATCC 33539), E. coli (ATCC 
13706), V. fischeri (ATCC 49387), A. hydrophilla (ATCC 7966), were purchased from 
ATCC collection. Fresh plate bacteria cultures were maintained in solid Tryptic Soy Agar 
medium (TSA; Merck, Darmstadt, Germany) at 4 °C. Before each assay, one isolated 
colony was aseptically transferred to 10 mL of Tryptic Soy Broth medium (TSB; Merck, 
Darmstadt, Germany) and was grown overnight at 25 °C. An aliquot of this culture (100 
µL) was aseptically transferred to 10 mL of fresh TSB medium and grown overnight at 25 
°C to reach an optical density (O.D. 600) of 0.8, corresponding to about 109 cells per mL. 
 
Host range determination and efficiency of phage infection 
 
To determine the phage host specificity, the double-layer agar method was used. 
Spot test was performed with twelve bacteria (V. parahaemolyticus, A. salmonicida, V. 
anguillarum, P. damselae subsp. damselae, E. coli (ATCC 13706), V. fischeri (ATCC 
49387), A. hydrophilla, P. aeruginosa, P. fluorescens, P. putida, P. segetis and P. gingeri) 
to assess the bacterial susceptibility to the bacteriophage (Vieira, et al. 2012). The plates 
were incubated at 37 ºC for 4 - 12 h. The efficiency of plating was determined for the 
bacteria with positive spot tests (occurrence of a lysis zone) by the double-layer agar 
method using TSA as culture medium. The efficiency of plating for each host was 
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calculated by comparison with an efficiency of 100% for the V. parahaemolyticus 
bacterium. For each phage, three independent experiments were done and the results were 
presented as the average of the three assays. 
 
Phage therapy assays  
 
Phage therapy was performed using three phages (VP-1, VP-2 and VP-3) using the 
bacterium V. parahaemolyticus as host. The assays were performed with single-phage 
suspensions and with a combination of phage with lysozyme (lysozyme from chicken egg 
white: Sigma-Aldrich: St. Louis, USA) at different concentrations (0.8, 1.6 µg mL-1, 3, 10 
and 20 mg mL-1). Preliminary assays, using the VP-2 phage with low lysozyme 
concentrations (0.8 and 1.6 µg mL-1) were done. After that, all three phages were tested in 
the presence of the highest lysozyme concentrations. 
 
Preliminary assays with VP-2 phage in the presence of low lysozyme concentrations 
 
The preliminary assays with VP-2 phage were performed in the presence of two 
lysozyme concentrations (0.8 and 1.6 µg mL-1). In order to obtain a MOI of 100, 105 CFU 
mL-1 of overnight grown V. parahaemolyticus culture and a 107 PFU mL-1 phage 
suspension were inoculated into 30 mL sterilized glass erlenmeyers with TSB medium. 
The lysozyme solution was added to two erlenmeyers, which were incubated at 25 ºC 
without agitation (test samples). Four control samples were also included, the bacterial 
control without lysozyme (BC), the phage control without lysozyme (PC), the bacterial 
control with lysozyme (BCL) and the phage control with lysozyme (PCL). The BC was not 
inoculated with the phage and the PC was inoculated with the phage but without the 
bacteria. The BCL was not inoculated with the phage but was inoculated with lysozyme, 
and the PCL was inoculated with the phage and lysozyme but without the bacteria. All 
controls were incubated exactly as the test samples. Aliquots of test samples and of the 
bacterial and phage controls were collected after 0, 2, 4, 6, 8, 10, 12, 18, 24 h of incubation 
for host and phage quantification in the test samples, for host quantification in the bacterial 
control and for phage quantification in the phage control. The bacterial concentration was 
determined in duplicate, by pour plating, in TSA medium after an incubation period of 24 
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h at 25 ºC. The phage titer was determined, in duplicate, by the double agar layer method, 
after an incubation period of 4 - 12 h at 25 ºC.  
 
Efficiency of VP-1, VP-2 and VP-3 phages in the presence of higher lysozyme 
concentrations 
 
The final assays were performed for all three phages (VP-1, VP-2 and VP-3) at a 
MOI of 100. For the VP-3 phage, assays were performed in the presence of three lysozyme 
concentrations (3, 10 and 20 mg mL-1) and for the other two phages, VP-1 and VP-2, only 
one lysozyme concentration was tested (10 mg mL-1). In order to obtain a MOI of 100, 
105 CFU mL-1 of the overnight V. parahaemolyticus culture and 107 PFU mL-1 of the 
phage suspension were inoculated into sterilized glass erlenmeyers with TSB medium 
(final volume of 30 mL). The lysozyme solution was added to the erlenmeyers, which were 
incubated at 25 ºC without agitation (test samples). Control samples (BC, BCL, BP and 
BPL) were also included. Aliquots of test samples and of the bacterial and phage controls 
were collected after 0, 2, 4, 6, 8, 10, 12, 18, 24 h of incubation for host and phage 
quantification as described above. Three independent experiments were performed for each 
condition. 
 
Statistical analysis 
 
Statistical analysis was performed using SPSS (SPSS 20.0 for Windows, SPSS Inc., 
USA). Normal distributions were checked by the Shapiro-Wilk test and homogeneity of 
variances was tested by the Levene test. The existence of significant differences among the 
different phage conditions was assessed by one-way analysis of variance (ANOVA) with 
the Tukey post-hoc test. For each situation, the significance of the differences was done by 
comparing the results obtained in the test samples after correction with the results obtained 
for the correspondent control samples (difference between the control and the test sample) 
for the different times of each of the three independent assays. A value of p < 0.05 was 
considered to be statistically significant. 
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Results 
 
Phages host range determination  
 
The VP-1 phage infected V. anguillarum and A. salmonicida, presenting an 
efficiency of 83.27 and 64.75%, respectively (Table 3.1). The VP-2 phage infected V. 
anguillarum and A. salmonicida presenting an efficiency of 93.39 and 92.03%, 
respectively (Table 3.1). The VP-3 phage also infected V. anguillarum and A. salmonicida, 
presenting an efficiency of 51.21 and 73.78%, respectively (Table 3.1). None of the three 
phages was effective against A. hydrophilla, P. damselae subsp. damselae, V. fischeri, E. 
coli, P. aeruginosa, P. fluorescens, P. putida, P. gingeri and P. segetis. 
 
Table 3.1- Efficiency of plating (%) of different bacteria. 
Fish bacteria 
Efficiency of phage plating (%) 
VP-1 VP-2 VP-3 
V. parahemolyticus 
V. anguillarum 
100 
83.27 
100 
93.39 
100 
51.21 
A. salmonicida 64.75 92.03 73.78 
A. hydrophilla 
V. fischeri 
0 
0 
0 
0 
0 
0 
P. damselae subsp. Damselae 0 0 0 
E. coli 
P. aeruginosa 
P. fluorescens 
P. putida 
P. segetis 
P. gingeri 
   0 
0 
0 
0 
0 
0 
   0 
0 
0 
0 
0 
0 
   0 
0 
0 
0 
0 
0 
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Phage therapy experiments 
 
Effect of low concentrations of lysozyme on the efficiency of phage therapy 
 
The maximum bacterial inactivation (ANOVA, p > 0.05) with the VP-2 phage was 
3.3 log, achieved after 4 h of phage therapy. When lysozyme at the concentrations of 0.8  
and 1.6 µg mL-1 was added, the maximum rate of bacterial inactivation was 3.2 log for 
both concentrations, after 4 h of incubation. Comparing the values of the bacterium control 
without lysozyme with the bacterium control with lysozyme, no significant differences 
were observed (ANOVA, p > 0.05) (Figure 3.1A). 
No decrease on the phage concentration was observed (ANOVA, p > 0.05) during 
the 24 h of the experiments for the phage control without lysozyme and for the phage 
control with lysozyme at 0.8 and 1.6 µg mL-1 (Figure 3.1B). When the phage alone and 
the phage in the presence of lysozyme were incubated in the presence of the host, an 
increase in the phage concentration (ANOVA, p < 0.05) was observed, but significant 
differences between the two samples were not observed during the 24 h experiment 
(ANOVA, p > 0.05) (Figure 3.1 B).  
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Figure 3.1 - Inactivation of V. parahaemolyticus by the VP-2 phage and by the VP-2 phage with lysozyme (0,8 µg mL-1 
and 1,6 ug mL-1) at a MOI of 100 during the 24 h of the experiment. A. bacterial concentration: BC – Bacteria control; 
BCL – Bacteria plus lysozyme. B. Phage concentration: PC – Phage control; PCL – Phage control with lysozyme; BP - 
Bacteria plus phage; BPL – Bacteria plus phage and lysozyme. Values represent the mean of three independent 
experiments; error bars indicate the standard deviation. 
 
Effect of high lysozyme concentrations on the efficiency of phage therapy 
 
The maximum of bacterial inactivation with VP-1 phage without the addition of 
lysozyme was 2.9 log, achieved after 6 h of incubation. However, the combination of the 
phage with lysozyme at 10 mg mL-1, reached a maximum of bacterial inactivation of 4 log 
after 2 h of incubation, being statistically different from the values obtained with the phage 
without lysozyme (ANOVA, p < 0.05). The difference between the two samples was 
statistically significant until 10 h of incubation (ANOVA, p < 0.05) (Figure 3.2A). 
The bacterial concentration in BC and in BCL was similar during the 24 h of 
incubation (ANOVA, p > 0.05) (Figure 3.2A).  
Phage survival did not decrease during the 24 h of the experiments, neither for the 
PC nor for PCL (Figure 3.2B). When the phage alone and the phage with lysozyme were 
incubated in the presence of the host, a significant increase of 0.7 log and 1.6 log, 
respectively, was observed after 24 h of incubation, being the difference between both 
samples statistically significant (ANOVA, p < 0.05) (Figure 3.2B).  
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Figure 3.2 - Inactivation of V. parahaemolyticus by the VP-1 phage alone and by the VP-1 phage in the presence of 
lysozyme (10 mg mL-1) at a MOI of 100 during the 24 h of the experiment. A. bacterial concentration: BC – Bacteria 
control; BCL – Bacteria plus lysozyme. B. Phage concentration: PC – Phage control; PCL – Phage control with 
lysozyme; BP - Bacteria plus phage; BPL – Bacteria plus phage and lysozyme. Values represent the mean of three 
independent experiments; error bars indicate the standard deviation. 
 
The maximum of bacterium inactivation with the VP-2 phage without lysozyme was 
3.6 log after 8 h of incubation. The assays with the combination of the phage and lysozyme 
at a concentration of 10 mg mL-1 were statistically significant from those without 
lysozyme, with a maximum of bacterial inactivation of 4 log after 4 h of incubation 
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(ANOVA, p < 0.05). The difference between the two samples was already observed after 2 
h of incubation, with reductions on the bacterial concentration of 3.5 log, when lysozyme 
was added to the samples, and of 0.8 log without the presence of lysozyme (ANOVA, p < 
0.05). After 12 h of phage therapy the rate of inactivation was still considerably high, but 
no significant differences were observed between both samples (ANOVA, p > 0.05) 
(Figure 3.3A). 
Comparing the values of the BC with the BCL during the 24 h experiment,  
significant differences were not observed (ANOVA, p > 0.05) (Figure 3.3A).  
The phage concentration did not decrease during the 24 h, for both the PC and PCL 
(Figure 3.3B). When the phage alone and the phage in the presence of lysozyme were 
incubated in the presence of the host, a significant increase of 0.7 log and 1.7 log, 
respectively, was observed after 24 h, and it was shown that the increase between the both 
controls was statistically significant (ANOVA, p < 0.05) (Figure 3.3B). 
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Figure 3.3 - Inactivation of V. parahaemolyticus by the VP-2 phage alone and by the VP-2 phage in the presence of 
lysozyme (10 mg mL-1) at a MOI of 100 during the 24 h of the experiment. A. bacterial concentration: BC – Bacteria 
control; BCL – Bacteria plus lysozyme. B. Phage concentration: PC – Phage control; PCL – Phage control with 
lysozyme; BP - Bacteria plus phage; BPL – Bacteria plus phage and lysozyme. Values represent the mean of three 
independent experiments; error bars indicate the standard deviation. 
 
The maximum of bacterial inactivation by the VP-3 phage was 3.8 log, achieved 
after 8 h, a value that is not statistically different from the one obtained when the lysozyme 
(10 mg mL-1) was added to the samples (bacterial reductions of 3.7 log) (ANOVA, p > 
0.05). For this phage, a higher lysozyme concentration (20 mg mL-1) was tested, but the 
results were similar to those obtained with 10 mg mL-1 (ANOVA, p > 0.05) (Figure 3.4A). 
A lower concentration of lysozyme (3 mg mL-1) was also tested for the VP-3 phage. The 
bacterial inactivation by the phage in the presence of 3 mg mL-1 of lysozyme was only 
significantly higher than that observed without lysozyme after 2 h of incubation (ANOVA, 
p < 0.05). After 4 h, the efficiency of inactivation was similar for the two samples 
(ANOVA, p > 0.05). However, after 6 h of incubation, the efficiency of phage therapy in 
the presence of 3 mg mL-1 of lysozyme was higher than that observed when lysozyme was 
used at 10 and 20 mg mL-1 (ANOVA, p < 0.05) (Figure 3.4A).  
Comparing the values of the BC with the values of the BCL during 24 h of 
incubation, significant differences were not observed (ANOVA, p > 0.05) (Figure 3.4A). 
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Phage concentration did not decrease during the 24 h of the experiments for PC and 
PCL in the presence of lysozyme at the concentrations of 3, 10 and 20 mg mL-1 (Figure 
3.4B). When the phage, in the presence of lysozyme (20 mg mL-1) was incubated with its 
host, a significant increase of 1.0 log was observed after 12 h of incubation. A similar 
increase was also observed when the phage was incubated in the presence of the bacteria 
but without lysozyme, however the increase was lower, being significantly different from 
that observed when lysozyme was added to the samples (ANOVA, p < 0.05) (Figure 3.4B). 
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Figure 3.4 - Inactivation of V. parahaemolyticus by the VP-3 phage alone and by the VP-3 phage in the presence of 
lysozyme (3 mg mL-1, 10 mg mL-1 and 20 mg mL-1) at a MOI of 100 during the 24 h of the experiment. A. bacterial 
concentration: BC – Bacteria control; BCL – Bacteria plus lysozyme. B. Phage concentration: PC – Phage control; PCL – 
Phage control with lysozyme; BP - Bacteria plus phage; BPL – Bacteria plus phage and lysozyme. Values represent the 
mean of three independent experiments; error bars indicate the standard deviation. 
 
Discussion 
 
The use of phages to inactivate different fish - pathogenic bacteria or to prevent 
bacterial infections in fish is well documented (Wu, et al., 1981, Stevenson & Airdrie, 
1984, Merino, et al., 1990, Nakai, et al., 1999, Munro, et al., 2003, Park & Nakai, 2003, 
Crothers-Stomps, et al., 2010). However, before phage therapy can be applied, it is 
necessary to develop effective protocols in order to efficiently inhibit the pathogenic 
bacteria, avoiding the emergence of resistance to the phages. Although the use of phage 
lytic enzymes (endolysins) has now been described to reduce the number of an extensive 
range of bacteria (Tsugita, et al., 1968, Borysowski, et al., 2006, Drulis-Kawa, et al., 2012, 
Díez-Martínez, et al., 2013), there is no report assessing the effect of phage therapy in the 
presence of lytic enzymes. 
In this study, the use of phage therapy in the presence of lysozyme for the control of 
Vibrio in aquaculture was described. The results of this study showed that the addition of 
lysozyme to the samples positively affected the activity of the phages. However, the 
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increase on phage efficiency is dependent on the type of phage and, from phage to phage, 
there was also observed a variation on the optimal lysozyme concentration. 
The three phages (VP-1, VP-2 and VP-3), in the presence of lysozyme, showed a 
higher efficiency to inactivate V. parahaemolyticus when compared with the results 
obtained with the phages alone. Moreover, the lytic effect was not observed when the 
lysozyme was used alone, which indicates that lysozyme improves the phages entrance 
into the host cells. The phage lytic enzymes lysis the bacteria, generally in a specie-specific 
manner (Tsugita, et al., 1968, Borysowski, et al., 2006, Drulis-Kawa, et al., 2012, Díez-
Martínez, et al., 2013), but non – phage lytic enzymes are also capable of degrading the 
peptidoglycan when externally applied (as purified proteins) to the bacterial cell wall, as 
observed with the egg lysozyme tested in this study. Although the egg lysozyme used in 
this study is not specie-specific, as the lysozyme alone has no lytic effect, the application 
of the enzyme with specific Vibrio phages turns out the treatment specific. 
VP-1 and VP-2 phages, in the presence of lysozyme at 10 mg mL
-1 (the more 
effective lysozyme concentration on the activity of the phages), showed a higher efficiency 
when compared with the results obtained with the phages alone. VP-1 phage, in the 
presence of lysozyme, achieved the maximum bacterial inactivation (4 log) after 2 h of 
incubation, which was almost 7 times higher than that obtained with the phage alone (0.6 
log). After 10 h of phage therapy, the value obtained in the presence of lysozyme was still 
significantly higher than that obtained in the assays of phage therapy with the phage alone. 
VP-2 phage, in the presence of the same lysozyme concentration, exhibited a very similar 
behaviour when compared with the VP-1 phage. The maximum bacterial inactivation (4 
log) was observed after 4 h of incubation and was almost 2 times higher than that obtained 
with the phage alone (2.3 log). At low lysozyme concentrations the activity of both phages 
(VP-1 and VP-2) was similar to that obtained with the phages alone. Unlike these two 
phages, the VP-3 phage only revealed an increase on its activity when lysozyme was added 
in a lower concentration (3 mg mL
-1
). The increase of VP-3 phage activity (3.2 log of 
inactivation) was only significantly different from the values obtained with VP-3 phage 
alone (2.6 log of bacterial inactivation) after 2 h of treatment (the activity increased by 
only 1.2 times). 
The differences in the activity of the three phages in the presence of lysozyme can be 
due to differences in infection efficiency of the phages. When the phage therapy was 
 82 
 
performed without the addition of lysozyme, the VP-3 phage was the phage presenting the 
highest rate of inactivation (2.9 log, 3.6 log and 3.8 log for VP-1, VP-2 and VP-3 phages, 
respectively). In addition, the maximum rate of inactivation for the VP-3 phage occurs 
soon after 2 h of phage therapy, which does not occur for the VP-1 and VP-2 phages alone 
(it happens after 6 h and 8 h, respectively). As the VP-3 phage is a very effective phage, 
the addition of lysozyme showed a low improvement on its activity when compared with 
the other less effective VP-1 and VP-2 phages. Moreover, the addition of higher lysozyme 
concentrations (10 and 20 mg mL
-1) also did not increase the efficiency of Vibrio 
inactivation by the VP-3 phage.  
Such results suggest that the addition of external lysozyme can improve the profile of 
less effective phages during phage therapy but, for more effective phages, the addition of 
lysozyme does not so clearly increase the efficiency of phage therapy, and may even cause 
a decrease in the bacterial inactivation if lysozyme is added at high concentrations. The 
increase in the efficiency of phage therapy in the presence of lysozyme seems to be due to 
an increase in the number of phages produced by the bacteria. For the VP-1 and VP-2 
phages, the number of phages produced when the lysozyme was added at 10 mg mL-1 was 
significantly higher than those produced when lysozyme was not added. For the VP-3 
phage the same was observed for the lysozyme concentration of 3 mg mL-1. Further studies 
including other phages and bacteria are necessary to confirm these hypotheses. Overall, the 
application of phage along with lysozyme can be a very useful strategy to eliminate or 
reduce fish pathogenic bacteria in aquaculture, to a level at which the host immune system 
is able to take over, namely when less effective phages are available. 
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Chapter 4: Conclusions and future perspectives 
 
In this work a serie of experiments to assess the sustainable of phage therapy to 
control fish pathogenic bacteria, namely the use of phage cocktails and the addition of lytic 
enzymes during phage therapy was done. 
The main conclusions of this work are summarized in the following topics: 
 
 The use of phage cocktails of two or three phages increase the efficiency of 
phage therapy against Vibrio, showing that the phage cocktails can be successfully 
used to treat Vibrio infections. Furthermore, the results indicate that although the 
use of cocktails did not avoid bacterial regrowth, but retarder the development of 
bacterial resistance. This retardation is an important reaching, delaying the 
development of resistance. 
 
 The externally addition of lysozyme, improves the profile of less effective 
phages during phage therapy (case of VP-1 and VP-2 phage), however for more 
effective phages the addition of lysozyme does not increase so clearly the 
efficiency of phage therapy, causing even a decrease in bacterial inactivation if the 
enzyme is added at high concentrations. Consequently, the application of the 
phages with lysozyme can be a very useful strategy to eliminate or reduce fish 
pathogenic bacteria in aquaculture to a level at which the host immune system is 
able to take over, namely when less effective phages are available. 
 
 The high efficiency of the three phages (isolated on V. parahaemolyticus) 
and their high periods of survival in marine aquaculture water indicate that these 
phages could to be suitable for use in phage therapy. 
 
 The use of phages with high burst size and short latent period improve 
clearly the efficiency of phage therapy. In this way, the phage VP-3 that presents a 
high burst size, and a short lytic cycle was more efficient to inactivate V. 
parahaemolyticus than VP-1 and VP-2 phages. 
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Regarding, the future work it is necessary to clearer the compression of the 
mechanisms of phage-resistant in order to improve the efficiency of phage therapy in vitro 
and in vivo. It will be also important to test the use of lytic enzymes with cocktails of 
phages. Moreover, it would be very interesting to evaluate what happens when the one-
step-growth curves are determined in the presence of lytic enzymes, in order to evaluate 
their effect on the burst size and explosion time. 
 
